US20150374302A1 - Metrics & algorithms for interpretation of muscular use including chronic muscle overuse index - Google Patents

Metrics & algorithms for interpretation of muscular use including chronic muscle overuse index Download PDF

Info

Publication number
US20150374302A1
US20150374302A1 US14/847,714 US201514847714A US2015374302A1 US 20150374302 A1 US20150374302 A1 US 20150374302A1 US 201514847714 A US201514847714 A US 201514847714A US 2015374302 A1 US2015374302 A1 US 2015374302A1
Authority
US
United States
Prior art keywords
data
semg
subject
amplitude
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/847,714
Inventor
Alexander B. Grey
Violetta Georgiou
Edward Frank Hejtmanek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somaxis Inc
Original Assignee
Somaxis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somaxis Inc filed Critical Somaxis Inc
Priority to US14/847,714 priority Critical patent/US20150374302A1/en
Publication of US20150374302A1 publication Critical patent/US20150374302A1/en
Assigned to SOMAXIS INCORPORATED reassignment SOMAXIS INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HEJTMANEK, EDWARD FRANK, BELANI, ABHISHEK, GREY, ALEXANDER B
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0006ECG or EEG signals
    • A61B5/0488
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/103Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
    • A61B5/112Gait analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/22Ergometry; Measuring muscular strength or the force of a muscular blow
    • A61B5/221Ergometry, e.g. by using bicycle type apparatus
    • A61B5/222Ergometry, e.g. by using bicycle type apparatus combined with detection or measurement of physiological parameters, e.g. heart rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/22Ergometry; Measuring muscular strength or the force of a muscular blow
    • A61B5/224Measuring muscular strength
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/296Bioelectric electrodes therefor specially adapted for particular uses for electromyography [EMG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/389Electromyography [EMG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/486Bio-feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4866Evaluating metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/68Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/683Means for maintaining contact with the body
    • A61B5/6832Means for maintaining contact with the body using adhesives
    • A61B5/6833Adhesive patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7246Details of waveform analysis using correlation, e.g. template matching or determination of similarity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/725Details of waveform analysis using specific filters therefor, e.g. Kalman or adaptive filters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271Specific aspects of physiological measurement analysis
    • A61B5/7275Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/74Details of notification to user or communication with user or patient ; user input means
    • A61B5/746Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2503/00Evaluating a particular growth phase or type of persons or animals
    • A61B2503/10Athletes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0223Operational features of calibration, e.g. protocols for calibrating sensors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02Operational features
    • A61B2560/0223Operational features of calibration, e.g. protocols for calibrating sensors
    • A61B2560/0238Means for recording calibration data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04Constructional details of apparatus
    • A61B2560/0406Constructional details of apparatus specially shaped apparatus housings
    • A61B2560/0412Low-profile patch shaped housings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/16Details of sensor housings or probes; Details of structural supports for sensors
    • A61B2562/164Details of sensor housings or probes; Details of structural supports for sensors the sensor is mounted in or on a conformable substrate or carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/01Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue

Definitions

  • sEMG surface electromyography
  • RMS instantaneous root mean square amplitude
  • mean/median power frequency The latter category can be referred to as an index of muscle fatigue.
  • these currently available metrics are limited in ability to adequately characterize muscular activation. Additionally, these metrics are geared towards researchers and professionals for use in medical diagnoses. Certain qualities/quantities of muscle activation that are significant to athletic or average consumers have not yet been developed, and there is currently a lack of protocols to automatically generate these metrics.
  • the sEMG assessments can be sorted into three general groups of muscle activity: static muscle activity, dynamic muscle activity, or combination of static and dynamic muscle activities.
  • the different muscle activity paradigms can be useful for different muscle assessments.
  • a static muscle activity may occur with no load (i.e. sitting) or with an isometric load (no movement of limb).
  • Static muscle activity evaluation can include observation of the rectified amplitude of the sEMG data.
  • the static muscle activity evaluation can be useful for a specific muscle or muscle group or as a comparison to other muscles or muscle groups.
  • Absolute levels of the sEMG data can be monitored through the RMS of the sEMG amplitude (e.g., RMS of sEMG amplitude), and abnormally large values of the RMS sEMG can be identified or determined.
  • Rhythmic contraction patterns of the muscle or muscle groups can be identified or determined, and may also be based on rectified amplitude.
  • a subject can exert an amount of force while keeping the limb fixed in a single position.
  • the force exerted is measured as a fixed percentage of Maximum Voluntary Contraction (MVC).
  • MVC Maximum Voluntary Contraction
  • MVC Maximum Voluntary Contraction
  • MPF mean power frequency
  • Dynamic muscle activity evaluations can ascertain relationships between sEMG amplitude and force, which have been shown to be “curvilinear”, or non-linear at the extremes of the force range (e.g., very little force, or a lot of force) and essentially linear for the majority of the force/amplitude relationship. Evaluating that relationship is useful for dynamic muscle activity sEMG evaluation.
  • Methods for implementing dynamic muscle activity evaluations can include incrementally increasing the force exerted by the muscle by way of a machine that measures force, and measuring the sEMG amplitude of the muscle activity that is associated with various force levels.
  • Dynamic muscle activity evaluations can be used in the evaluation of torque and paralysis. There are dynamic muscle activity evaluation methods for: muscle imbalance, trigger points, cocontractions, and fasciculations.
  • the abovementioned muscle assessment methods can be used to assess a variety of pathologies and physiological states which may correspond to, or attempt to correspond to, clinical and/or medical conditions. These methods have typically been designed to be performed by specialists (e.g., MD, chiropractor, physical therapist, etc.). These muscle assessment methods are usually restricted to controlled settings in the presence of these specialists. Thus, there is not a way for a common person to implement muscular assessment on their own. Therefore, there remains a need to bring the ability to implement muscle assessment to the masses.
  • specialists e.g., MD, chiropractor, physical therapist, etc.
  • FIG. 1A is a depiction of the method of determining the muscle fatigue onset index (MFOI) conversion factor from the regular time interval graph.
  • MFOI muscle fatigue onset index
  • FIG. 1B is a depiction of sEMG data taken at regular intervals on a MPF vs. time.
  • FIG. 2A is a depiction of the method of determining MFOI conversion factor with data taken continuously and fitting a line to maximum amplitudes recorded.
  • FIG. 2B is a depiction of sEMG data taken continuously, with the maximum amplitudes recorded and fitted to a line.
  • FIG. 3A is a depiction of the method of determining MFOI conversion factor with data taken continuously and fitting a line to the average amplitudes recorded per interval of time.
  • FIG. 3B is a depiction of sEMG data taken continuously, with the average amplitudes per interval of time recorded and fitted to a line.
  • FIG. 4A is a depiction of the method for determining the chronic muscle overuse index (CMOI) conversion factor using amplitude values to aid the subject in preventing injury by estimating a time beyond which it is more likely for a subject to experience an injury.
  • CMOI chronic muscle overuse index
  • FIG. 4B is a depiction of sEMG data gathered to determine the CMOI conversion factor for a new subject on an amplitude vs. time graph with the maximum and minimum noted.
  • FIG. 4C is a depiction of the amplitude vs. time data for the average subject based on the related average dataset similar to the data gathered for the new subject, which when compared to the new subject data is used to create the CMOI conversion factor.
  • FIG. 4D is a depiction of estimated amplitude vs. time data based on the application of the CMOI conversion factor to the recorded new subject data.
  • FIG. 5A is a depiction of the method for determining the CMOI conversion factor using mean power frequency (MPF) values to aid the subject in preventing injury by estimating a time beyond which it is more likely for a subject to experience an injury.
  • MPF mean power frequency
  • FIG. 5B is a depiction of MPF vs. time data for the average subject based on the related average dataset similar to the data gathered for the new subject, which when compared to the new subject data is used to create the CMOI conversion factor.
  • FIG. 5D is a depiction of the rate of change for non-ideal conditions on the MPF vs. time graph.
  • FIG. 5C is a depiction of MPF vs. time data for the average subject based on the related average dataset similar to the data gathered for the new subject, which when compared to the new subject data is used to create the CMOI conversion factor.
  • FIG. 5D is a depiction of the rate of change for non-ideal conditions on the MPF vs. time graph.
  • FIG. 5E is a depiction of the rate of change for ideal conditions on the MPF vs. time graph.
  • FIG. 5F is a depiction of the MPF vs. time graph used to determine an estimated time to muscle exhaustion based on the application of the frequency based CMOI conversion factor to the new subject data.
  • FIG. 5G is a depiction of the rate of change for non-ideal conditions on the amplitude vs. time graph for determining the amplitude based CMOI conversion factor.
  • FIG. 5H is a depiction of the rate of change for non-ideal conditions on the amplitude vs. time graph used to determine a conversion factor and estimated time to muscle exhaustion based on the application to the new subject data.
  • FIG. 5I is a depiction of the method for determining the estimated time to muscle exhaustion based on the relationship between the actual rate of change observed and the rate of change of the related average dataset.
  • FIG. 5J is a depiction of the amplitude vs. time graph and the safety zones developed from the data gathered in the amplitude based CMOI method to aid the subject in preventing injury.
  • FIG. 5K is a depiction of the MPF vs. time graph and the safety zones developed from the data gathered in the frequency based CMOI method to aid the subject in preventing injury.
  • FIG. 6 is a depiction of a computing system that, in one embodiment, may be used to perform the methods disclosed herein.
  • FIG. 7A is a depiction of the amplitude vs. time graph where the peak amplitude of the new subject data is used to determine a first warm-up indicator in creating.
  • FIG. 7B is a depiction of the MPF vs. time graph where the point corresponding to the indicator shown in FIG. 7A is noted.
  • FIG. 7C is a depiction of the amplitude vs. time graph where the first warm-up indicator is noted, as well as the amplitude corresponding to a time based warm-up indicator and average subject input, both being based on a related average dataset.
  • FIG. 7D is a depiction of the MPF vs. time graph where the points corresponding to the indicators shown in FIG. 7C are noted.
  • FIG. 7E is a depiction of the subject-amplitude method of determining a new subject warm-up indicator based on new subject data and a related average dataset.
  • FIG. 7F is a depiction of the subject-frequency method of determining a new subject warm-up indicator based on new subject data and a related average dataset.
  • FIG. 8A is a depiction of the current state of the art for measuring maximum voluntary control MVC in a controlled environment and a part of the combined database used to determine the impulsive muscle overuse index (IMOI) conversion factor.
  • IMOI impulsive muscle overuse index
  • FIG. 8B is a depiction of the system data-gathering pseudo maximum voluntary control (PMVC) measurement in a semi-controlled environment.
  • PMVC pseudo maximum voluntary control
  • FIG. 8C is a depiction of the method for producing a new subject IMOI, or an MVC estimate, using the PMVC.
  • FIG. 9A is a depiction of a system for measuring and estimating work for various activities using the Muscle Work Estimation Index (MWEI) conversion factor.
  • MWEI Muscle Work Estimation Index
  • FIG. 9B is a depiction of the amplitude vs. time graph of the data gathered for the new subject activity to be used in creating an MWEI conversion factor.
  • FIG. 9C is a depiction of the work vs. time graph of the data gathered for the new subject activity to be used in creating an MWEI conversion factor.
  • FIG. 9D is a depiction of an integral of the amplitude vs. time graph for a related average dataset, where the area under the curve is useful in calculating the MWEI conversion factor for a given activity.
  • FIG. 9E is a depiction of an integral of the amplitude vs. time graph of new subject data, where the area under the curve is useful in calculating the MWEI conversion factor for any given activity.
  • FIG. 10A is a depiction of the sEMG data displayed on an amplitude vs. time graph useful in determining the slow-twitch muscle index (STMI) conversion factor, and the fast-twitch muscle index (FTMI) conversion factor, noting points including an inflection point before which fast-twitch fibers dominate the activity and after which slow-twitch fibers dominate the activity.
  • STMI slow-twitch muscle index
  • FTMI fast-twitch muscle index
  • FIG. 10B is a depiction of the MPF vs. time graph noting points from FIG. 10A and their corresponding points on the MPF vs. time graph.
  • FIG. 10C is a depiction of the amplitude vs. time graph where a buffer range is optionally used to account for errors in determining the inflection point.
  • FIG. 11A is a depiction of the rate of change of an individual's personal mutli-dimensional fitness index (PMFI) index over time.
  • PMFI personal mutli-dimensional fitness index
  • FIG. 11B is a depiction of the rate of change of one individual's PMFI over time compared to another individual's PMFI index over time.
  • the present invention relates to systems and methods of implementing the assessment of muscle activation and performance by analyzing muscle data with algorithms and metrics.
  • subject includes a user such as physical fitness consumer.
  • the method can be utilized by a user to determine metrics useful in understanding the fitness of the user's own body alone, as compared to other user's metrics, and/or as compared to an average user's related metrics.
  • systems and methods including a computing system to gather a dataset of subject (e.g., a user of the system or method) who is engaged in an activity.
  • the user's dataset is gathered, in part, from one or more of sensors or data gathering devices including: a surface electromyometry (sEMG) sensor attached to the skin of the user, temperature sensors attached to the user, heart rate sensors attached to the user, and the like.
  • sensors or data gathering devices including: a surface electromyometry (sEMG) sensor attached to the skin of the user, temperature sensors attached to the user, heart rate sensors attached to the user, and the like.
  • Each sensor or data gathering device is operably coupled to the computing system.
  • the computing system selects one or more muscle assessment protocols as directed by the user, automatically as determined by a predetermined decision, or even by a third party. The protocols selected will then configure the data necessary to properly determine the metric for the user engaged the activity, tailored for the activity, and the user.
  • the metrics allow the user, or other third party, to assessing any of the following such as: the user's muscle condition, the user's muscle activity, a related average dataset based on average user's referenced in a database, projected estimates for the user's activity, and the like.
  • the computing system monitors and/or records relevant data of the users engaged in the activity.
  • the computing system may also concurrently, or subsequently, monitor the data of other users engaged in the activity.
  • Some metrics require a calibration period be used to gather data at ideal conditions for the user.
  • an ideal condition may be a 0° incline as opposed to a non-ideal condition such as a non-0° incline.
  • the resulting metrics determine and assess the user's muscle activity as described above, but also are useful in determining a conversion factor to apply new estimates for activities performed under non-ideal conditions.
  • the muscle data is provided as sEMG data, which can be processed by various algorithms in order to obtain metrics related to muscle activation and performance.
  • the systems and methods can be designed to automatically calculate the metrics by sensors, processors, and computer-readable mediums.
  • the systems can include hardware and software configured to perform the steps of the method described herein.
  • RMS amplitude can be described as an algorithm that is used to “rectify” a sEMG signal. If RMS is calculated, every data point (e.g., no “down sampling”) effectively yields the absolute value of the incoming data points.
  • the RMS amplitude is a useful way of interpreting sEMG data coming from muscles.
  • RMS can be used for many other kinds of interpretive analyses that may be performed with sEMG data. For instance, the average rectified value over a period of time can be calculated based on RMS data instead of using raw or raw and filtered data.
  • RMS can also be used for the following amplitude based metrics described herein.
  • the methods of methods of implementing the assessment of muscle activation and performance can be performed with any subject.
  • the subject can wear one or more sensors on one or more muscles that are going to be used during a muscle activity, where the sensors may or may not be operably coupled to a computing device that is also worn by the subject during the muscle activity.
  • This computing device may record muscle data during the muscle activity, and it may also even have wireless access to a network and may be able to record the data on a server or database in real time. Additionally, the computing device that is capable of accessing a remote server or database over a network may be able to access muscle data or muscle activity metrics of other subjects that have performed a substantially similar muscle activity.
  • the similarity of muscle activities can arise by the muscle activities being part of a predetermined muscle activity, which allows for comparison of muscle data and metrics across one or more populations of subjects.
  • the other subjects can be filtered for physiological condition, size, weight, age or the like with respect to the subject that is primarily performing the muscle activity.
  • the muscle data or metrics can be compared in real time with information provided to the subject engaged in the muscle activity on the fly, or the data and metrics can be saved and the comparison can be done with a computing system after completion of the predetermined muscle activity.
  • the database may also be accessed for muscle data and metrics for the same subject so that they can compare the activation and function of a current predetermined activity with a past implementation of the predetermined activity.
  • the ability to access muscle data and metrics from a database can allow for the subject to statistically generate estimates of the muscle data and metrics that is useful for determining muscle condition.
  • the comparison between data gathered for the new subject and a related average dataset is used to generate a conversion factor.
  • the conversion factor is useful in generating a number of different metrics as will be shown below.
  • the computing device can gather a dataset for a new subject.
  • This dataset can include both the new subject's primary sEMG data, such as the amplitude of the sEMG graph, the mean power frequency (MPF), the maximum voluntary contraction (MVC), the heart rate (HR), the temperature of the subject, and secondary data such as height, weight, type of activity, and the like.
  • the data can be plotted on a graph representing the new subject's current data.
  • the computing device can then reference the database to determine a related average dataset.
  • a related average dataset can be created from referencing a large number of statistically significant past measurements for other subjects. It is important to note that the related average dataset can account for the secondary data as well as primary data. The related average dataset may even be a prior implementation of the muscle activity of the same subject.
  • the computing system can then determine a conversion factor based on the relationship of the new subject data to the related average dataset.
  • a conversion factor can provide information about the relationship of the subjects muscle condition compared to the other subjects muscle condition.
  • a conversion factor can be determined for different metrics, alone or in combination, useful in analyzing the new subject's muscle activity and overall fitness level. The method for determining a conversion factor can be illustrated below.
  • the methods described herein can be used to perform useful estimations of muscle health, muscle condition, caloric burn, work performed, safety estimations, and the like. Frequently, the example of running is used. However, it should be understood that these indexes and algorithms can be applied to continuous muscle activities (e.g., bicycling, swimming, cycling, and the like) or noncontinuous muscle activities (e.g., weight-lifting), as well as any number of other muscle activities that are conducive to sEMG-based analysis, which can be any static or dynamic muscle activity.
  • continuous muscle activities e.g., bicycling, swimming, cycling, and the like
  • noncontinuous muscle activities e.g., weight-lifting
  • MFOI Muscle Fatigue Onset Index
  • the mean power frequency can represent an average activation frequency of a muscular contraction, which can be measured during a short time period.
  • MFOI describes the rate of change of the MPF over a period of time. It has been shown that as a muscle becomes fatigued, the MPF decreases. However, the MPF alone may not be useful to a subject, and may not help the subject determine how “fit” their muscles are. This can be applied to overall condition of the muscles, not just how strong the muscles are, but more importantly the rate of change of the fatigue onset in their muscles.
  • MFOI can be described as the average rate at which a muscle becomes fatigued.
  • the MFOI and the MFOI conversion factor are muscle metrics that can be provided to individuals to assist in enhanced training for improvement of physical activities.
  • the MFOI is determined through MFOI protocol by selecting the MFOI protocol.
  • the MFOI protocol will configure data relevant to the MFOI metric such as the MPF, and duration.
  • the data for MFOI can be gathered by measurements at set time intervals, continuously measuring peak amplitudes, continuously measuring average amplitudes, and the like. As the data is plotted to an MPF versus time graph, the slope of the line fitted to the data will determine the MFOI.
  • MFOI can allow for an easily comparable metric across individuals and populations that describe how quickly an average individuals' muscles become fatigued, and the MFOI conversion factor can allow for a new subject to estimate how quickly the new subject's muscles will become fatigued. Therefore MFOI and the MFOI conversion factor can be an important consideration for how “fit” the individual is.
  • the sensors worn by the subject can measure muscle data and determine metrics related to muscle activation and function. As such, various variables can be determined for the MFOI and the MFOI conversion factor.
  • the frequency sampling rate (FSR) is an example of one variable in an algorithm for determining the MFOI and the MFOI conversion factor.
  • the total length of time of the activity (AT) is another second variable.
  • the quantity of total samples can be defined by Equation 1.
  • FIG. 1A depicts a general method 150 of muscle assessment that can be used in determining the MFOI and the MFOI conversion factor.
  • the method 150 can include: gathering MPF values for a subject engaging in a certain activity (block 151 ); plotting MPF values on a graph allowing for a line to be fitted to the plotted points (block 152 ); and determining the slope of the line, where the slope is the MFOI (block 153 ).
  • the amplitudes of the movements are identified automatically by the computing device for each regular time interval from data obtained from the sensors associated with the muscles.
  • the computing device can utilize hardware (e.g., processors) and software on computer-readable mediums configured to carry out the steps of the method 150 reflected in FIG.
  • the MFOI conversion factor is determined by dividing the MFOI (block 153 ) by the average MFOI.
  • the MFOI conversion factor is useful in assessing muscle fatigue onset of one subject compared to an average subject, and can estimate amplitudes over time for that subject.
  • the line representing the plotted data can have a non-positive slope.
  • the slope of the line can be thought of as MFOI, which describes the subject's average rate of change of the MPF over time.
  • MFOI can be performed in which for regular periodic movement (e.g., such as running, bicycling, swimming, or weightlifting) the peak amplitudes of these regular movements are identified automatically by the computing device from data obtained from the sensors associated with the muscles.
  • the computing device can utilize hardware (e.g., processors) and software on computer-readable mediums configured to carry out the steps of the method 250 reflected in FIG. 2A , which can be implemented for determining MFOI with periodic movement data and peak amplitudes.
  • the MPF values at peak amplitudes are gathered for a subject engaging in a certain activity (block 251 ); a graph is generated and a line is fit according to the MPF values at peak amplitudes (block 252 ); and the slope of the line is taken resulting in MFOI (block 253 ).
  • the graph and line thereof are illustrated in FIG. 2B .
  • Another implementation for obtaining MFOI and the MFOI conversion factor can be performed in which for regular periodic movement (e.g., such as running, bicycling, swimming, or weightlifting) the averaged MPF in pre-set epochs can be used compared with FSR in which periodic samples are taken from a larger data set.
  • regular periodic movement e.g., such as running, bicycling, swimming, or weightlifting
  • FSR frequency range
  • This can be conducted in a method 350 for determining a subject's average MFOI and the MFOI conversion factor with periodic movement, which is illustrated in FIG. 3A .
  • the average MPF amplitudes are gathered for a subject engaging in a certain activity for certain epochs (block 351 ; a graph is generated and a line is fit according to MPF values at average amplitudes (block 352 ); and the slope of the line is taken resulting in MFOI (block 353 ).
  • the MFOI conversion factor may be determined by referencing a database to determine a related average dataset.
  • the method for determining the MFOI conversion factor for the method 250 and the method 350 is the same as the method for determining the MFOI conversion factor described above in method 150 .
  • the conversion factor is determined by a computing device gathering a dataset for a new subject. Once data has been gathered, a graph is generated and a line or a curve is fit according the data associated with each metric. Significant data values can be derived from the graph. In some metrics, such as MFOI, the significant data value is the slope of the line. In other metrics, significant data values may be the initial maximum amplitude, the final amplitude, the difference between the values, the work done by the activity, the temperature of the subject, the heart rate of the subject, the maximum voluntary contraction, the median power frequency, the mean frequency, any combination of the aforementioned values, and the like. Once significant values are determined, a database is referenced that determines a related average dataset. The conversion factor is based on the relationship between a subject's dataset and a related average dataset. In general, a conversion factor can be associated with any of the following, or aforementioned, metrics to assess muscular activity, alone or in combination.
  • the MFOI methods include the utilization of the MPF. Additionally, the MFOI can include the MPF in conjunction with amplitude values (e.g., combination terms which take the amplitude, and then add a term which utilizes the MPF or rate of change of the MPF). So if the amplitude is A, and the rate of change of the MPF is R, then the term for the combination method could be: A*c 1 +R*c 2 , where c 1 and c 2 are constants determined through database comparison or through past data recorded from the user, or a combination of both.
  • amplitude e.g., combination terms which take the amplitude, and then add a term which utilizes the MPF or rate of change of the MPF. So if the amplitude is A, and the rate of change of the MPF is R, then the term for the combination method could be: A*c 1 +R*c 2 , where c 1 and c 2 are constants determined through database comparison or through past data recorded from the user, or a combination of
  • another embodiment can include taking particular slices of the frequency spectrum, and use those slices in the calculation of the MPF. This can be done instead of taking the whole frequency range to produce the MPF. For instance, if measuring from 50-500 Hz for sEMG, the MPF can be calculated based only upon 80 Hz-150 Hz. Alternatively, it can be calculated based on two regions (e.g., 20-40 Hz and 80-150 Hz), where each MPF calculation from each frequency range is multiplied by a constant which assigns significance. Other manipulations to frequency domain can be performed to produce more complex versions of a frequency characterization.
  • CMOI Chronic Muscle Overuse Index
  • CMOI chronic muscle overuse index
  • CMOI protocol can include an initial calibration where the user engages in an activity under ideal conditions. As data is gathered, the CMOI protocol will configure data relevant to the CMOI metric such as the sEMG amplitude, sEMG MPF, and duration. CMOI can be calculated by either the amplitude data gathered or by MPF data gathered. The data is plotted to either amplitude versus time graph, or MPF versus time graph. The CMOI protocol determines an average related dataset by referencing a database of other average users. CMOI is then developed based on the relationship between the dataset and the related average dataset. Finally, a conversion factor is found to determine CMOI for a non-ideal condition.
  • CMOI protocol can include an initial calibration where the user engages in an activity under ideal conditions. As data is gathered, the CMOI protocol will configure data relevant to the CMOI metric such as the sEMG amplitude, sEMG MPF, and duration. CMOI can be calculated by either the amplitude data
  • a new subject first conducts a safe calibration run for a short time at a slow/moderate speed in a controlled environment (e.g., for example: treadmill, 15:00 minutes, 4.0 mph, 0° incline).
  • a method 450 of calculating an amplitude-based CMOI is illustrated in FIG. 4A .
  • secondary subject data are gathered prior to or during a calibration run (block 451 ).
  • the new subject performs a calibration run during which maximum and minimum amplitude data is gathered (block 452 ).
  • the data is then referenced with respect to similar data of a database to establish a related average dataset (block 453 ).
  • the CMOI is calculated based on similarities of the new subject data collected during the calibration run compared to the related average dataset (block 454 ). This CMOI helps to estimate the time to exhaustion the new subject will experience for subsequent runs. However, this can be performed for any muscle activity.
  • FIG. 4B graphically shows how the calculations are performed.
  • the amplitude high-point for this segment is recorded as H 0
  • the low-point is saved as L 0
  • the difference between the two is assigned to ⁇ 1 .
  • a database is referenced with respect to similar data including primary and secondary data such as demographics (e.g., subject age, height, weight, activity type, muscle in question) to obtain a similar CMOI and/or similar ⁇ 1 .
  • demographics e.g., subject age, height, weight, activity type, muscle in question
  • the database returns a number of datasets (e.g., at least 35 datasets for statistical significance), which together produce a number of average values: H (average) 411 , L 1(average) 413 , ⁇ 1(average) 415 , ⁇ 2(average) 417 , L 2(average) 419 , T 2(average) 421 .
  • H (average) 411 is the average high-point amplitude of subjects in the database.
  • L 1(average) 413 is the average low-point amplitude of subjects in the database.
  • ⁇ 1(average) 415 is the difference between H (average) 411 and L 1(average) 413 .
  • T 2(average) 421 is the time at which subjects in the database experience perceived muscular exhaustion, and/or observable loss of coordination.
  • L 2(average) 419 is the amplitude at which subjects in the database experienced perceived muscular exhaustion, and/or observable loss of coordination.
  • ⁇ 2(average) 417 is the difference between H (average) 411 and L 2(average) 419 .
  • L 2(estimated) 431 is calculated by Equation 2.
  • T 2(estimated) 433 is also calculated by Equation 3.
  • a new subject In a frequency-based CMOI calculation, a new subject first conducts a safe calibration run for a short time at a slow/moderate speed in a controlled environment (for example: treadmill, 15:00 minutes, 4.0 mph, 0° incline).
  • a muscle assessment method 550 can be conducted as described in order to determine a CMOI, which method is shown in FIG. 5A .
  • the secondary new subject data is gathered such as subject age, height, weight, activity type, or the like (block 552 ).
  • the new subject primary data, including maximum and minimum MPF data, is gathered during a calibration activity (block 554 ).
  • the database for the muscle activity is referenced to identify and/or obtain data for others that have similar demographics and/or similar CMOI in order to establish a related average dataset (block 555 ).
  • the estimated time to muscle exhaustion is produced based on the corresponding similarities of new subject data and the related average dataset (block 558 ).
  • the data obtained during the method 550 can be used to produce the CMOI frequency based metrics that are graphically represented in FIGS. 5B-5E .
  • the calibration run produces the maximum frequency (MPF i ) 501 , a final/minimum frequency (MPF f ) 503 , the difference between the MPF i and the MPF f ( ⁇ 2 ) 505 , the time change ( ⁇ t) 507 , and the MFOI 509 represented by the MFOI equation 511 .
  • the database is referenced to build an average dataset that is similar to the data gathered.
  • the database returns some number of datasets (e.g., at least 35 data sets for statistical significance).
  • the database referencing produces a number of average values: MPF i(average) 521 , MPF f1(average) 523 , ⁇ 1(average) 525 , MPF f2(average) 527 , T 2(average) 529 , ⁇ 2(average) 531 .
  • MPF i(average) 521 is the average high-point MPF of subjects in the database.
  • MPF f1(average) 523 is the average low-point MPF of subjects in the database.
  • ⁇ 1(average) 525 is the difference between MPF i(average) 521 and MPF f1(average) 523 .
  • T 2(average) 529 is the time at which subjects in the database experience perceived muscular exhaustion, and/or observable loss of coordination.
  • MPF f2(average) 527 is the amplitude at which subjects in the database experienced perceived muscular exhaustion, and/or observable loss of coordination.
  • ⁇ 2(average) 531 is the difference between MPF i(average) 521 and MPF f2(average) 527 .
  • MPF 2(estimated) 541 is then calculated for the new subject.
  • MPF 2(estimated) 541 is the estimated MPF at which the new subject will experience muscular exhaustion, and is calculated by Equation 4.
  • T 2 is the time associated with an individual subject entry in the database.
  • T 2(estimated) 543 the estimated time to new subject exhaustion, is defined by Equation 5.
  • an observed rate of change can be calculated, and a CMOI conversion factor can be calculated.
  • This rate of change can then be used to calculate times to exhaustion for subsequent activities of the same subject, even under differing conditions. For instance, as shown in FIGS. 5G and 5H for amplitude data, the observed rate of change can be observed for either a 0° incline or a non-0° incline, allowing for a conversion factor to be generated.
  • This conversion factor can be adjusted for variables in the physical environment, which cause the subject to fatigue faster than expected. One method of doing this is based on the observed rate of change (ROC) of amplitude.
  • ROC observed rate of change
  • the rate of change on a non-0° incline ROC actual which when divided by the observed rate of change of amplitude ROC0° (for 0° incline), produces the desired conversion factor.
  • This conversion factor can be regularly recalculated by Equation 6.
  • the estimated time of exhaustion may be calculated from the information previously provided by the related average dataset, and as explained when calculating the safety zones discussed below.
  • the method for creating these zones is explained shown in FIG. 5I .
  • the relevant data is gathered by measuring maximum values (block 551 ).
  • the database is referenced with respect to similar data to establish a related average dataset (block 553 ).
  • Safety zones are calculated based on the conversion factor as input (block 557 ).
  • these estimated zones are associated with either an amplitude or a frequency, the corresponding times can be calculated for these times zones.
  • These visualization aids essentially break down the amplitude range (e.g., from start until final average amplitude at the exhaustion point for the relevant database subset that is returned) into a number of easy-to-visualize categories. In one embodiment, this may be done in a color code that is intuitive to subjects, such as Green, Yellow, Orange, and Red.
  • the Green Zone can begin at H 0 571 and continues until, but not including, H 1 572 calculated by Equation 7.
  • H 1 [H 0 ⁇ ( H 0 ⁇ L 2(estimated) )/3] Equation 7
  • the Yellow Zone begins at H 1 572 , but not including and continues until, but not including, H 2 573 calculated by Equation 8.
  • H 2 [H 1 ⁇ (2*( H 0 ⁇ L 2(estimated) )/3)] Equation 8
  • the Orange Zone begins at H 2 573 and continues until, but not including, L 2(estimated) 574 as calculated by the equation listed above in Equation 2. It should be noted that the present invention contemplates a plurality of zones as required by the subject represented by Equation 9.
  • H (n+1) [H n ⁇ (( n+ 1)*( H 0 ⁇ L 2(estimated) )/3)] Equation 9
  • the Red Zone is any amplitude greater than or equal to L 2(estimated) 574 .
  • these amplitude divisions corresponding to safety zones may be converted to estimate times for each zone.
  • the Green Zone begins at MPF i 580 and continues until, but not including, MPF 1 581 calculated by Equation 10.
  • MPF 1 [MPF i ⁇ ( MPF i ⁇ MPF 2(estimated) )/3] Equation 10
  • the Yellow Zone begins at MPF 1 581 and continues until, but not including, MPF 2 582 calculated by Equation 10a.
  • MPF 2 [MPF 1 ⁇ (2*( MPF i ⁇ MPF 2(estimated) )/3)] Equation 10a
  • the Orange Zone begins at MPF 2 582 and continues until, but not including, MPF 2(estimated) 583 calculated by Equation 2. It should be noted that the present invention contemplates a plurality of zones as required by the subject represented by Equation 10b.
  • MPF (n+1) [MPF n ⁇ (( n+ 1)*( MPF i ⁇ MPF 2(estimated) )/3)] Equation 10b
  • these MPF divisions corresponding to safety zones may be converted to estimate times for each zone. Additionally, the estimated time of exhaustion, T 2(estimated) , may be calculated from the information provided from calculating the safety zones.
  • a conversion factor can be calculated for subsequent activities during a frequency-based calculation as in FIG. 5B and FIG. 5C .
  • This conversion factor would adjust for variables in the physical environment which cause the subject to fatigue faster than expected.
  • One method of doing this is based on the observed rate of change (ROC) of MPF, or aka the MFOI.
  • ROC observed rate of change
  • MFOI the rate of change on a non-0° incline ROC actual , which when divided by the observed rate of change of amplitude ROC 0° (for 0° incline), produces the desired conversion factor.
  • This conversion factor can be regularly recalculated by Equation 10c.
  • WUI warm-up index
  • the WUI is derived from the method to develop CMOI.
  • amplitude-based WUI and frequency-based WUI
  • the maximum amplitude of the resulting amplitude vs. time curve can be used as a time corresponding to a first point of being warmed up as shown in FIG. 7A .
  • the corresponding MPF associated with the time of the max amplitude can also be used as shown in FIG. 7B .
  • a database can be referenced through which some number of (e.g., at least 35) data subsets are analyzed, providing different available methods for establishing whether the subject is warmed up.
  • the subjects in the database associated with subsets used can have similar characteristics to the new subject such as physical characteristics, similarities in recorded data or secondary metrics such as MFOI, or the like.
  • a number of reference points are recorded for each type of data: the high-point amplitude and corresponding MPF, the amplitude corresponding to a time-based warm-up that is known to be effective based on the database results, for example, 10 minutes, and corresponding MPF for that time is a second warm-up point.
  • the new subject can also reference the database referencing instead a subject-input experience marker where the subject's in the database feel warmed up and a corresponding time indicating a third warm-up point.
  • the subject can find the corresponding MPF associated with that subject-input experience time marker. In this way, an inexperienced subject can benefit from different available methods for establishing whether they are warmed up sufficiently.
  • amplitude-based WUI and frequency-based WUI.
  • the present invention can include a “work done” WUI, which simply sums up the amplitudes over time (e.g., the area under the graph, or integrated signal).
  • the work done can be a simple sum of the RMS sEMG, or it can be FBAAR, or TBAAR (time-based amplitude adjusted).
  • a given target warm-up value based on work done can be calculated the first time based on a database reference for users of similar age, height, weight, or the like. Subsequently, users can also establish time markers that set a work-done goal for the warm-up based on how they are feeling. Note that this is also related to the “Muscle Work Estimation Index.”
  • FIG. 7E depicts the method 770 of producing a new subject amplitude-based WUI.
  • new subject secondary data is gathered during safety calibration activity (block 771 ).
  • second, new subject sEMG data is gathered for the new subject (block 772 ).
  • Fourth, the database is queried with respect to similar sEMG and secondary data to establish a related average dataset (block 776 ).
  • an estimated time to warm up is determined based on the subset's average time to warm up (block 778 ).
  • the WUI conversion factor is determined by observing the relationship to the subject data and the average related dataset. Similar to other methods aforementioned, a WUI conversion factor can aid in estimating a warm-up time for a subject engaged in various activities.
  • FIG. 7F depicts a similar method 780 of producing a new subject estimate for WUI based on a frequency reading.
  • new subject secondary data is gathered during safety calibration activity (block 781 ).
  • new subject sEMG data is gathered for the new subject (block 782 ).
  • new subject sEMG frequency data and secondary new subject data entered into a database (block 784 ).
  • the database is queried with respect to similar sEMG and secondary data to establish a related subset (block 786 .
  • an estimated time to warm up is determined based on the subset's average time to warm up (block 788 ).
  • the frequency based WUI conversion factor is determined by observing the relationship to the subject data and the average related dataset. Similar to other methods aforementioned, a WUI conversion factor can aid in estimating a warm-up time for a subject engaged in various activities.
  • method 770 or method 780 can be used to establish the WUI based on either related average subject data or related average subject direct input.
  • IMOI Impulsive Muscle Overuse Index
  • PMVC Pseudo MVC
  • MVC Maximum voluntary contraction
  • FIG. 8A shows one embodiment of a method 800 of obtaining a MVC reading as shown with wireless sensors 804 (e.g., sEMG sensor) that send the sEMG data 806 wirelessly to a computing device 808 , it is contemplated by this invention that readings can be taken wirelessly, wired, or otherwise.
  • wireless sensors 804 e.g., sEMG sensor
  • the method 800 can be implemented during any type of muscle activity, such as weightlifting with a weight machine 802 as illustrated.
  • “Impulsive overuse” defines a safety threshold in relation to the instantaneous force generated by a single muscle contraction. This threshold is typically established by means of calculation of the MVC of an individual. It is known that operating above MVC force levels is dangerous. Excessive muscular contraction force can result in muscle injury, tendon injury, etc. Because of this known danger, the IMOI is proposed as a metric to aid athletes.
  • IMOI is determined through IMOI protocol by selecting the IMOI protocol.
  • IMOI requires an initial calibration where the user engages in an activity under a semi-controlled environment.
  • the IMOI protocol will configure data relevant to the IMOI metric such as pseudo MVC (PMVC) explained in detail below.
  • PMVC pseudo MVC
  • IMOI is determined based on the association of PMVC with known MVC data to create a related average dataset.
  • the IMOI protocol determines a safety force threshold on the basis of the related average dataset.
  • PMVC Pulseudo MVC
  • the second metric is rectified sEMG, or sEMG amplitude data, which is measured at different force levels. This can include both PMVC and MVC.
  • PMVC is calculated by way of isometric activities performed in semi-controlled environmental conditions such as is shown in FIG. 8B .
  • FIG. 8B shows a subject having a sensor 804 that provides sEMG 806 to a computing device 808 while the subject lifts free-weights 810 .
  • PMVC is a method for taking readings in semi-controlled environments. For instance, if the weight of a subject is known, and the subject stands on “tip toes” for a time, then the force on each gastrocnemius muscle can be estimated. This is an oversimplified example of a PMVC activity. There are a number of different kinds of isometric activities which subjects can easily and quickly perform which generate estimated force values. During each PMVC and MVC activity in the database, the sEMG amplitude is recorded.
  • a method 820 for determining PMVC is depicted in FIG. 8C .
  • the first reference database is comprised of many data sets which include “real MVC” performed in a completely controlled environment, as well as a number of separate PMVC values.
  • the sEMG amplitude is measured for both MVC and PMVC.
  • a new subject e.g., who is not in the database
  • the database can be used to correlate the PMVC to MVCs for individuals who have similar physical properties.
  • the third step of the method 820 is to reference the new subject data with a combined PMVC/MVC database to develop a related average dataset (block 826 ).
  • the next step is to estimate MVC for the semi-controlled PMVC activity based on the dataset (block 828 ).
  • Direct mathematical conversion between PMVC and MVC (with a calculated and disclosed error range) is also possible, without consulting the database using a PMVC/MVC conversion factor.
  • a PMVC/MVC conversion factor is determined by modeling or approximating the relationships found within the database between PMVC and MVC.
  • IMOI are calculated by way of the following algorithmic process: a) a new subject decides they would like to know their IMOI for a given muscle group; b) the subject must enter information about themselves such as height, weight, age, or the like into the system; c) the subject selects an appropriate PMVC activity, and performs the activity while recording sEMG amplitude; d) the database is called, and the subset corresponding to age, height, specific muscle being measured, PMVC activity type, etc.
  • Equation 11 the conversion factor (CF) between PMVC and MVC for that subset is calculated by Equation 11.
  • CR is the conversion ratio calculated by Equation 12.
  • the algorithm can include: h) the sEMG amplitude measured by the new subject (from step “c”) is multiplied by the conversion factor CF (step “g”). Assuming that the activity coordinators are comfortable with 100% MVC being the practical safety limit, this calculated value is the IMOI (e.g., measured in microvolts). This is the safety threshold. An embodiment of this metric can be used in a real time feedback device that notifies the subject when he/she is approaching the threshold.
  • the above-calculated IMOI value in step “h” is multiplied by the appropriate percentage (e.g., in this case, 0.7). Then, the resulting value (e.g., in microvolts) is the IMOI.
  • FIG. 9A illustrates a subject riding a bike 902 that has a work sensor 904 (e.g., work ergometer) while wearing a leg sensor 906 .
  • the sensors 904 , 906 wirelessly communicate data 907 to a computing device 908 .
  • a database is needed to correlate work done with the integral of a rectified sEMG graph (e.g., area under the curve of a rectified sEMG graph).
  • the database can be built with subject information.
  • MWEI is determined through MWEI protocol by selecting the MWEI protocol.
  • MWEI requires an initial calibration where the user engages in an activity under a semi-controlled environment.
  • the MWEI protocol will configure data relevant to the MWEI metric such as integrated sEMG amplitude and work output.
  • MWEI is determined based on the association of sEMG amplitude data with work output data to create a related average dataset conversion factor. The MWEI protocol thus allows sEMG data to be converted to work done.
  • each person whose data is entered into the database discloses secondary subject data such as age, height, weight, and a number of other physiological measurements which they either already know or which can be easily determined experimentally (e.g., such as measuring body mass index, BMI).
  • the subjects perform specified activities in a semi-controlled environment (e.g., rowing machine, stationary bike, treadmill, resistance training machine, or the like).
  • a semi-controlled environment e.g., rowing machine, stationary bike, treadmill, resistance training machine, or the like.
  • sEMG amplitude is being measured the entire time that subjects are performing the activity.
  • Equation 13 Integrated sEMG is shown by Equation 13.
  • MWEI is determined by Equation 16.
  • caloric expenditure is estimated by way of measuring an individual's heart rate (HR) and then using that measurement in a very general formula to determine caloric burn.
  • HR heart rate
  • calculating caloric expenditure based on heart rate is inherently crude estimation, and as such contains a high likelihood of error/inaccuracy for any given individual.
  • heart rate is a relatively inexpensive estimation method (e.g., because heart rate monitors have become relatively inexpensive), it lacks accuracy and specificity based on muscle type, activity type, or the like.
  • a database can be used to provide a more robust estimate of caloric burn.
  • This database can be multidimensional, and can be sorted by muscle, by activity, and by secondary factors such as: age of subject, BMI of subject, height of subject, as well as a number of other factors as mentioned in databases required for other methods/metrics listed herein.
  • the function of this database is to correlate the caloric expenditure of certain activities with the area under the curve of the rectified sEMG graph recorded during those activities.
  • the database can be created by performing activities that are “simple”: a single muscle performing a single action, while recording the caloric expenditure of that single action as well as the area under the rectified sEMG graph for that single action.
  • the protocol can use the most accurate measures of caloric expenditure available.
  • SMCI is determined through SMCI protocol by selecting the SMCI protocol.
  • SMCI requires an initial calibration where the user engages in an activity.
  • the SMCI protocol will configure data relevant to the SMCI metric such as integrated sEMG amplitude and caloric expenditure.
  • SMCI is determined based on the association of sEMG amplitude data with caloric expenditure data to create a related average dataset conversion factor associating sEMG data with an average caloric burn.
  • the SMCI protocol thus allows sEMG data to be converted to caloric expenditure.
  • the SMCI can be used for a single muscle, or multiple muscle groups.
  • a conversion factor is created, including some additional steps. This is done by first creating a conversion factor associating the total number of calories burned with the area under the subject's rectified sEMG data curve for that particular muscle, represented by Equation 17:
  • Equation 18 For multiple muscles or multiple muscle groups associated with the same activity, the conversion factor can be modified by Equation 18:
  • the database is referenced, and the area under the subject's rectified sEMG data curve for that particular muscle, or multiple muscles/muscle groups be correlated with an associated caloric cost.
  • the new subject's integral rectified of sEMG data has been converted to an associated caloric burn, the new subject's SMCI can be calculated.
  • SMCI is calculated by gathering a subset from the database based on data related to the new subject's data, producing a subset of a number of (e.g., at least 35) subjects in the subset, and a conversion factor for each.
  • An average conversion factor is calculated by Equation 19:
  • a SMCI can be tailored for the subject and for the activity.
  • muscles which are primary contributors to the caloric cost of the activity.
  • running and bicycling result in caloric expenditure that is primarily due to core muscle activation and lower extremity activation (e.g., gluteus muscles, leg muscles).
  • Monitoring the sEMG output of these muscles will produce a more tailored estimate of caloric expenditure which uses the electrical output of the muscles to estimate caloric burn, instead of status-quo Heart Rate-only methods.
  • CMCI Cardio-Skeletal Muscle Calorie Index
  • the cardio-skeletal muscle calorie index is similar to the Skeletal Muscle Calorie Index.
  • the major differentiating factor is that two databases are utilized, however, and they may be combined into a single database. Essentially, this is a combination index which utilizes previously established heart rate-only methods of caloric expenditure, and also estimates of calories burned based on the more accurate skeletal muscle calorie index as well.
  • CMCI is determined through CMCI protocol by selecting the CMCI protocol.
  • CMCI requires an initial calibration where the user engages in an activity.
  • the CMCI protocol will configure data relevant to the CMCI metric such as integrated sEMG amplitude and heart rate (HR) data.
  • HR heart rate
  • CMCI is determined based on the association of sEMG amplitude data with HR data and a known HR caloric expenditure database to create a related average dataset conversion factor associating sEMG data with an average caloric expediture.
  • the CMCI protocol thus allows sEMG data to be converted to caloric expenditure.
  • the CMCI can optionally be calculated with weights on sEMG amplitude or HR caloric expenditure as determined to appropriate.
  • CMCI CMCI is then calculated by Equation 21.
  • An individual performs a muscle activity, and the HR and rectified sEMG data are both recorded for the duration of the activity.
  • a previously established database determines the relationship between HR and calorie burn can be obtained or determined, producing an estimate of calories burned (CHR).
  • the second database such as the SMCI database expressed above, empirically establishes the conversion factor by the relationship between rectified sEMG data and calories burned using the area under the rectified sEMG curve, and produces a second estimate of calories burned (CRS).
  • CRS calories burned
  • This equation expresses equal weights on each database, however, different weights can be assigned to either the CHR value or the CRS value depending on preference.
  • Muscle Activation Symmetry Index (MASI) and Normalized Muscle Activation Symmetry Index (NMASI)
  • Muscle activation refers to rectified sEMG amplitude.
  • Symmetry refers to left-side and/or right-side muscles, such as the left quadriceps femoris and the right quadriceps femoris.
  • Normalized refers to a database which describes normal variation in symmetry found in sEMG measurements during particular activities derived from a series of studies using statistically significant numbers of subjects. Symmetry in this context can refer to a logically grouped pair of muscles.
  • Instantaneous left-side amplitude is the rectified sEMG amplitude of a muscle on the left side of the body.
  • Instantaneous right-side amplitude is the rectified sEMG amplitude of a muscle on the right side of the body.
  • MASI is defined by Equation 22.
  • MASI is determined through MASI protocol by selecting the MASI protocol.
  • MASI requires an initial calibration where the user engages in an activity.
  • the MASI protocol will configure data relevant to the MASI metric such as rectified sEMG amplitude for the right and left side of a symmetrical muscle group.
  • MASI is the difference between the right side and left side amplitude.
  • the difference index MASI when compared to the normalized difference index NMASI, can help describe the manner an individual performs a certain type of physical activity. For example, if it is known that for 1000 subjects who have had the rectified sEMG amplitude of their left and right quadriceps femoris measured while swimming 100 meters, the average NMASI can be shown to be 50 microvolts, then this normalized difference index can be used when a new subject decides to swim 100 meters while measuring their sEMG amplitude. If the new subject's MASI is 30 microvolts, then they are within a normal difference index range for that muscle group, that activity, and that particular subset of subjects which correlate to the new subject's physical characteristics. In other words, if MASI ⁇ NMASI, the difference index is normal. If MASI>NMASI, difference index is not normal.
  • Lack of normality can indicate different situations. It could indicate a recruitment pattern (e.g., learned behavior) that is asymmetrical. If that is the case, then the individual would benefit from training and re-education. It could indicate that the subject has an injury on one side of their body, and is favoring the other side. If that is the case, then the subject should probably not yet be performing that activity (e.g., possibly because a subject is not fully recovered from injury yet). It could also indicate that one side of the subject's body is significantly stronger than the other side. If that is the case, then the subject should strengthen the side of their body that is weaker. Regardless, MASI versus NMASI is a valuable tool for individuals who perform physical activities that require equal force from both sides of their bodies.
  • a recruitment pattern e.g., learned behavior
  • MWDI Muscle Work Difference Index
  • NMWDI Normalized Muscle Work Difference Index
  • Muscle work difference index (MWDI) and normalized work difference index (NMWDI) are similar to MASI, but they differ from MASI in a few significant ways.
  • MWDI Muscle work difference index
  • NMWDI normalized work difference index
  • the simplest way to clearly define MWDI or its counterpart NMWDI is to describe the difference between MASI and MWDI.
  • MWDI may compare the difference between left versus right in a single group, but may also compare one muscle group to another. For instance, right biceps brachii can be compared to right triceps brachii during an isotonic machine bench-press. MWDI may also compare a work difference index for two individuals with the measurement being performed on exactly the same muscle. It may also be a work difference index for the same individual, and the same muscle, but on different days and/or at different times.
  • MWDI utilizes muscular work estimation index (MWEI) explained above.
  • MWDI is a comparison of work done, not of sEMG amplitude observed. While these are proportional, the difference observed is affected by the conversion factor used to convert between amplitude over time and/or area under the curve to work done. In this sense, since numbers describing work done are always larger than numbers describing instantaneous activation levels (e.g., an extra dimension of time is utilized, as well as the amplitude dimension) it is a more sensitive measurement. Additionally, this measure allows for more comparisons over time and a more complete understanding of how a muscle works.
  • MWEI muscular work estimation index
  • MWDI is determined through MWDI protocol by selecting the MWDI protocol.
  • the MWDI protocol in turn utilizes the MWEI protocol aforemention.
  • the MWDI protocol determines at least a first value and a second value representing the work done for each muscle or muscle group measured. MWDI is the difference between the first value and the second value. This is useful when compared to past datasets, average datasets of the same user or average datasets for other users. An average dataset comparison is called the NWDI.
  • the slow-twitch muscle indexes are a family of metrics that are extracted from a single calibration activity, not a database.
  • STMI is derived from a method for graphical/analytical filtering (e.g., viewing only slow-twitch fiber activation) as well as a method for quantifying slow-twitch fiber activation in a variety of ways, including maximum amplitude of slow-twitch muscle fiber activation, average amplitude of slow-twitch muscle fiber activation, rate of fatigue of slow-twitch muscle fibers, length of time required before slow-twitch fibers become the primary force behind an activity, and work done by slow-twitch fibers during an activity.
  • STMI is determined through STMI protocol by selecting the STMI protocol.
  • the STMI protocol gathers sEMG data and then measures the inflection point.
  • the inflection point is determined on the graph of sEMG amplitude versus time or the corresponding MPF versus time.
  • the inflection point represents the point at which fast-twitch muscle fibers become a secondary force to slow-twitch muscle fibers.
  • An individual who wishes to determine “how much” and “for how long” their slow-twitch muscle fibers activate during physical activity first applies sensors and/or devices for the measurement of sEMG amplitude and frequency. The individual then performs the activity, which is rate-controlled and exertion-controlled to the greatest extent possible. For example, if a runner wishes to determine their STMI, they might apply sensors, and then run on a treadmill for 30 minutes at 5.5 mph, with a fixed stride rate of 120 heel strikes per minute (hspm). As shown in FIG. 10A , the resultant sEMG amplitude graph is observed, and the inflection point between the initial rate of change decrease and secondary rate of change decrease is marked. In FIG.
  • the graph of MPF versus time is superimposed on the graph of amplitude versus time, so that at the point of inflection noted, the MPF of that transition point can be likewise determined.
  • a band-pass filter is implemented retroactively on the graph, with the allowed frequency range being equal to or less than the MPF of the transition point. Since initially observed amplitudes and frequencies are due to fast-twitch fiber activation, and these fibers become relatively quickly fatigued, by filtering out the frequencies above the MPF of the transition point, the fast-twitch fibers are eliminated from the observed data.
  • Initial amplitude being 2000 microvolts (average); Initial MPF being 180 Hz; Inflection point time being 12 minutes; Inflection point amplitude being 800 microvolts; Inflection point frequency being 100 Hz; Final amplitude being 100 microvolts; Final MPF being 70 Hz; and/or STMI band-pass filter set-up being 5-100 Hz.
  • Slow-Twitch Muscle Index STMI
  • the maximum amplitude of slow-twitch muscle fiber activation can include the maximum amplitude being the amplitude of the rectified sEMG graph at the inflection point.
  • the average amplitude of slow-twitch muscle fiber activation can be the average amplitude of the rectified sEMG graph from the inflection point until the end of the session.
  • the rate of fatigue of slow-twitch muscle fibers can be calculated by looking at the slope of a line, or rate of change, which is fit to the graph of MPF versus time, from the point of inflection until the final point, represented by Equation 25.
  • the change in time is the length of time required before slow-twitch fibers become the primary force behind an activity. This is the amount of time until the inflection point.
  • the area under the curve of the rectified sEMG graph can also be converted to calories burned by the slow-twitch fibers by conversion through skeletal muscle calorie index (SMCI) database referencing, if desired.
  • SMCI skeletal muscle calorie index
  • the STMI may be configured with a buffer range. A buffer range may be necessary in order to account for errors in the measurement as shown in FIG. 10C .
  • the fast-twitch muscle index includes a family of indexes which are closely related to the STMIs; however, as expected, a band-pass filter is created for all data points after detection of the inflection point, rather than for all points before the inflection point in the STMI method.
  • FTMI is determined through FTMI protocol by selecting the FTMI protocol.
  • the FTMI protocol gathers sEMG data and then measures the inflection point.
  • the inflection point is determined on the graph of sEMG amplitude versus time or the corresponding MPF versus time.
  • the inflection point represents the point at which fast-twitch muscle fibers become a secondary force to slow-twitch muscle fibers.
  • the maximum amplitude of fast-twitch muscle fiber activation is determined, which is the maximum amplitude of the rectified sEMG graph observed prior to the inflection point. It should be noted that the figures for the slow-twitch protocols can be used for fast-twitch protocols.
  • an average amplitude of fast-twitch muscle fiber activation can be determined. This is the average amplitude of the rectified sEMG graph from the start of the session until the inflection.
  • the rate of fatigue of fast-twitch muscle fibers can also be determined, which is calculated by looking at the slope of a line which is fit to the graph of MPF versus time, from the start point until the point of inflection as expressed in Equation 25 above.
  • the work done by fast-twitch fibers during an activity can be calculated by taking the integral of the rectified sEMG graph, from the first point until the inflection point. Then, the MWEI and associated conversion factor, is utilized to convert area under the curve to work done as represented by Equation 27.
  • the area under the curve of the rectified sEMG graph can be converted to calories burned by the slow-twitch fibers by conversion through SMCI database referencing, if desired.
  • the FTMI may be configured with a buffer range. A buffer range may be necessary in order to account for errors in the measurement.
  • PMFI Personal Multidimensional Fitness Index
  • the personal multidimensional fitness index is a mutli-factor metric which describes the fitness level of an individual at a particular point in time, as shown in FIG. 11A .
  • PMFI can describe the fitness level of different individuals over time as shown by FIG. 11B . While there are many fitness metrics in use today, this metric differentiates itself by including sEMG-based factors such as the MFOI.
  • PMFI is determined through PMFI protocol by selecting the PMFI protocol.
  • the PMFI protocol gathers data related to some of the aforementioned metrics, and aggregates the resultant values to create PMFI.
  • an individual can perform an activity for a length of time that is non-negligible (more than a few minutes). For example, in one embodiment, a runner might run for 30 minutes or whatever their typical exercise might be. In this manner, the MFOI is calculated, which has a negative value. The less in shape an individual's muscles are, more negative the MFOI becomes. The closer to 0 the slope of the graph of MPF over time is, the more in shape an individual's muscles are.
  • Another factor may be based on MASI.
  • the symmetry index is also recorded (e.g., MASI). The closer MASI is to 0, the more in shape the subject is.
  • the HR of the individual is measured during the activity.
  • each individual has a target HR for physical activity which involves a cardiovascular component (e.g., basically all physical activities). The closer to the target HR an individual is, the more in-shape they are, cardiovascularly speaking.
  • the BMI of an individual can be utilized in the PMFI metric. It can be estimated in a number of ways, including a simplistic estimation based on the subject's height and weight. The closer to their ideal BMI a subject is, the more in-shape the subject is. In other words, the closer to zero the difference between ideal BMI and actual BMI is zero, the more in-shape the individual is.
  • maximum oxygen consumption (e.g., VO 2 _max) can be utilized as well.
  • PMFI is calculated by Equation 28 or a normalized version thereof.
  • n is a non-critical constant determined experimentally.
  • n can be set to provide a spread with a range that is intuitive to subjects who wish to look at the number and quickly assess their personal fitness level.
  • each term has been set up in such a way so that if the subject is in ideal shape, PMFI will be close in range to the constant “n.” Alternatively, if the subject is out of shape, PMFI will be comparatively far from the constant “n.”
  • the invention described herein can be implemented with the sensors or systems described in U.S. Provisional Application Nos. 61/385,048 and 61/514,148 and U.S. patent application Ser. No. 13/239,033. Additionally, the invention described herein can be implemented with metrics and algorithms described in U.S. Provisional Application No. 61/385,046 and U.S. patent application Ser. No. 13/239,105. Also, the invention described herein can be implemented with methods of promoting fitness described in U.S. Provisional Application No. 61/385,053 and U.S. patent application Ser. No. 13/239,079. Further, the invention described herein can be implemented with graphing methods described in U.S. Provisional Application No. 61/385,049.
  • the invention described herein can be implemented with the multi-functional carrying case and associated biometric sensors and transceivers described in U.S. Provisional Application No. 61/385,051.
  • the invention described herein can be implemented with the devices, systems, and/or methods described in U.S. Pat. Nos. 7,593,769 and 7,809,435.
  • the patents and patent applications recited herein are incorporated herein by specific reference in their entirety.
  • the present methods can include aspects performed on a computing system.
  • the computing system can include a memory device that has the computer-executable instructions for performing the method.
  • the computer-executable instructions can be part of a computer program product that includes one or more algorithms for performing any of the methods of any of the claims.
  • any of the operations, processes, methods, or steps described herein can be implemented as computer-readable instructions stored on a computer-readable medium.
  • the computer-readable instructions can be executed by a processor of a wide range of computing systems from desktop computing systems, portable computing systems, tablet computing systems, hand-held computing systems and/or any other computing device.
  • the implementer may opt for a mainly hardware and/or firmware vehicle; if flexibility is paramount, the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware.
  • a signal bearing medium examples include, but are not limited to, the following: a recordable type medium such as a floppy disk, a hard disk drive, a CD, a DVD, a digital tape, a computer memory, etc.; and a transmission type medium such as a digital and/or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link, etc.).
  • a typical data processing system generally includes one or more of a system unit housing, a video display device, a memory such as volatile and non-volatile memory, processors such as microprocessors and digital signal processors, computational entities such as operating systems, drivers, graphical subject interfaces, and applications programs, one or more interaction devices, such as a touch pad or screen, and/or control systems including feedback loops and control motors (e.g., feedback for sensing position and/or velocity; control motors for moving and/or adjusting components and/or quantities).
  • a typical data processing system may be implemented utilizing any suitable commercially available components, such as those generally found in data computing/communication and/or network computing/communication systems.
  • any two components so associated can also be viewed as being “operably connected”, or “operably coupled”, to each other to achieve the desired functionality, and any two components capable of being so associated can also be viewed as being “operably couplable”, to each other to achieve the desired functionality.
  • operably couplable include but are not limited to physically mateable and/or physically interacting components and/or wirelessly interactable and/or wirelessly interacting components and/or logically interacting and/or logically interactable components.
  • FIG. 6 shows an example computing device 600 that is arranged to perform any of the computing methods described herein.
  • computing device 600 In a very basic configuration 602 , computing device 600 generally includes one or more processors 604 and a system memory 606 .
  • a memory bus 608 may be used for communicating between processor 604 and system memory 606 .
  • processor 604 may be of any type including but not limited to a microprocessor ( ⁇ P), a microcontroller ( ⁇ C), a digital signal processor (DSP), or any combination thereof.
  • Processor 604 may include one more levels of caching, such as a level one cache 610 and a level two cache 612 , a processor core 614 , and registers 616 .
  • An example processor core 614 may include an arithmetic logic unit (ALU), a floating point unit (FPU), a digital signal processing core (DSP Core), or any combination thereof.
  • An example memory controller 618 may also be used with processor 604 , or in some implementations memory controller 618 may be an internal part of processor 604 .
  • system memory 606 may be of any type including but not limited to volatile memory (such as RAM), non-volatile memory (such as ROM, flash memory, etc.) or any combination thereof.
  • System memory 606 may include an operating system 620 , one or more applications 622 , and program data 624 .
  • Application 622 may include a determination application 626 that is arranged to perform the functions as described herein including those described with respect to methods described herein.
  • Program Data 624 may include determination information 628 that may be useful for analyzing the contamination characteristics provided by the sensor unit 240 .
  • application 622 may be arranged to operate with program data 624 on operating system 620 such that the work performed by untrusted computing nodes can be verified as described herein.
  • This described basic configuration 602 is illustrated in FIG. 6 by those components within the inner dashed line.
  • Computing device 600 may have additional features or functionality, and additional interfaces to facilitate communications between basic configuration 602 and any required devices and interfaces.
  • a bus/interface controller 630 may be used to facilitate communications between basic configuration 602 and one or more data storage devices 632 via a storage interface bus 634 .
  • Data storage devices 632 may be removable storage devices 636 , non-removable storage devices 638 , or a combination thereof. Examples of removable storage and non-removable storage devices include magnetic disk devices such as flexible disk drives and hard-disk drives (HDD), optical disk drives such as compact disk (CD) drives or digital versatile disk (DVD) drives, solid state drives (SSD), and tape drives to name a few.
  • Example computer storage media may include volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information, such as computer readable instructions, data structures, program modules, or other data.
  • Computer storage media includes, but is not limited to, RAM, ROM, EEPROM, flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which may be used to store the desired information and which may be accessed by computing device 600 . Any such computer storage media may be part of computing device 600 .
  • Computing device 600 may also include an interface bus 640 for facilitating communication from various interface devices (e.g., output devices 642 , peripheral interfaces 644 , and communication devices 646 ) to basic configuration 602 via bus/interface controller 630 .
  • Example output devices 642 include a graphics processing unit 648 and an audio processing unit 650 , which may be configured to communicate to various external devices such as a display or speakers via one or more A/V ports 652 .
  • Example peripheral interfaces 644 include a serial interface controller 654 or a parallel interface controller 656 , which may be configured to communicate with external devices such as input devices (e.g., keyboard, mouse, pen, voice input device, touch input device, etc.) or other peripheral devices (e.g., printer, scanner, etc.) via one or more I/O ports 658 .
  • An example communication device 646 includes a network controller 660 , which may be arranged to facilitate communications with one or more other computing devices 662 over a network communication link via one or more communication ports 664 .
  • the network communication link may be one example of a communication media.
  • Communication media may generally be embodied by computer readable instructions, data structures, program modules, or other data in a modulated data signal, such as a carrier wave or other transport mechanism, and may include any information delivery media.
  • a “modulated data signal” may be a signal that has one or more of its characteristics set or changed in such a manner as to encode information in the signal.
  • communication media may include wired media such as a wired network or direct-wired connection, and wireless media such as acoustic, radio frequency (RF), microwave, infrared (IR) and other wireless media.
  • RF radio frequency
  • IR infrared
  • the term computer readable media as used herein may include both storage media and communication media.
  • Computing device 600 may be implemented as a portion of a small-form factor portable (or mobile) electronic device such as a cell phone, a personal data assistant (PDA), a personal media player device, a wireless web-watch device, a personal headset device, an application specific device, or a hybrid device that include any of the above functions.
  • Computing device 600 may also be implemented as a personal computer including both laptop computer and non-laptop computer configurations.
  • the computing device 600 can also be any type of network computing device.
  • the computing device 600 can also be an automated system as described herein.
  • the embodiments described herein may include the use of a special purpose or general-purpose computer including various computer hardware or software modules.
  • Embodiments within the scope of the present invention also include computer-readable media for carrying or having computer-executable instructions or data structures stored thereon.
  • Such computer-readable media can be any available media that can be accessed by a general purpose or special purpose computer.
  • Such computer-readable media can comprise RAM, ROM, EEPROM, CD-ROM or other optical disk storage, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to carry or store desired program code means in the form of computer-executable instructions or data structures and which can be accessed by a general purpose or special purpose computer.
  • Computer-executable instructions comprise, for example, instructions and data which cause a general purpose computer, special purpose computer, or special purpose processing device to perform a certain function or group of functions.
  • module can refer to software objects or routines that execute on the computing system.
  • the different components, modules, engines, and services described herein may be implemented as objects or processes that execute on the computing system (e.g., as separate threads). While the system and methods described herein are preferably implemented in software, implementations in hardware or a combination of software and hardware are also possible and contemplated.
  • a “computing entity” may be any computing system as previously defined herein, or any module or combination of modulates running on a computing system.
  • a range includes each individual member.
  • a group having 1-3 cells refers to groups having 1, 2, or 3 cells.
  • a group having 1-5 cells refers to groups having 1, 2, 3, 4, or 5 cells, and so forth.

Abstract

A muscle assessment method utilizing a computing system, surface electromyometry (sEMG) sensors, and other sensors to gather data for one or more subjects engaged in an activity through operably coupling the one or more sensors to the computing system, and directing a computing system to select one or more muscle assessment protocols related to a number of different metrics. For a user subject engaged in a physical activity, assessing muscle condition, the muscle activity, and statistically related averages provide information to the user and about muscle and whole body fitness.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This patent application is a division of, and claims priority to, U.S. patent application Ser. No. 13/239,064 entitled “METRICS AND ALGORITHMS FOR INTERPRETATION OF MUSCULAR USE” filed on Sep. 21, 2011. This patent application also claims the benefit of and priority to U.S. Provisional Application Ser. Nos. 61/385,046, 61/385,038, 61/385,048, 61/385,049, 61/385,051, and 61/385,053 all of which were filed on Sep. 21, 2010. In addition, this patent application claims the benefit of U.S. Provisional Application No. 61/514,148, filed Aug. 2, 2011. All of the aforementioned patent applications are incorporated herein by specific reference in their entirety.
  • BACKGROUND OF THE INVENTION
  • Currently, various metrics are used to describe properties of muscular activation and function. Often, the measurement of muscle activation and function is measured by surface electromyography (sEMG), and analysis of the sEMG can include the following: the instantaneous root mean square amplitude (RMS), the average rectified amplitude, and the mean/median power frequency. The latter category can be referred to as an index of muscle fatigue. However, these currently available metrics are limited in ability to adequately characterize muscular activation. Additionally, these metrics are geared towards researchers and professionals for use in medical diagnoses. Certain qualities/quantities of muscle activation that are significant to athletic or average consumers have not yet been developed, and there is currently a lack of protocols to automatically generate these metrics.
  • The sEMG assessments can be sorted into three general groups of muscle activity: static muscle activity, dynamic muscle activity, or combination of static and dynamic muscle activities. The different muscle activity paradigms can be useful for different muscle assessments.
  • A static muscle activity may occur with no load (i.e. sitting) or with an isometric load (no movement of limb). Static muscle activity evaluation can include observation of the rectified amplitude of the sEMG data. The static muscle activity evaluation can be useful for a specific muscle or muscle group or as a comparison to other muscles or muscle groups. Absolute levels of the sEMG data can be monitored through the RMS of the sEMG amplitude (e.g., RMS of sEMG amplitude), and abnormally large values of the RMS sEMG can be identified or determined. Rhythmic contraction patterns of the muscle or muscle groups can be identified or determined, and may also be based on rectified amplitude. During an isometric loading protocol, a subject can exert an amount of force while keeping the limb fixed in a single position. Usually, the force exerted is measured as a fixed percentage of Maximum Voluntary Contraction (MVC). Then, the median frequency (MF) or mean power frequency (MPF) can be measured or determined by observing or analyzing the frequency spectrum of the sEMG. In this manner, the fatigue level of the muscles can be established, and the point at which fatigue begins to occur may be identified.
  • Dynamic muscle activity evaluations can ascertain relationships between sEMG amplitude and force, which have been shown to be “curvilinear”, or non-linear at the extremes of the force range (e.g., very little force, or a lot of force) and essentially linear for the majority of the force/amplitude relationship. Evaluating that relationship is useful for dynamic muscle activity sEMG evaluation. Methods for implementing dynamic muscle activity evaluations can include incrementally increasing the force exerted by the muscle by way of a machine that measures force, and measuring the sEMG amplitude of the muscle activity that is associated with various force levels. Dynamic muscle activity evaluations can be used in the evaluation of torque and paralysis. There are dynamic muscle activity evaluation methods for: muscle imbalance, trigger points, cocontractions, and fasciculations.
  • However, the abovementioned muscle assessment methods can be used to assess a variety of pathologies and physiological states which may correspond to, or attempt to correspond to, clinical and/or medical conditions. These methods have typically been designed to be performed by specialists (e.g., MD, chiropractor, physical therapist, etc.). These muscle assessment methods are usually restricted to controlled settings in the presence of these specialists. Thus, there is not a way for a common person to implement muscular assessment on their own. Therefore, there remains a need to bring the ability to implement muscle assessment to the masses.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The foregoing and following information as well as other features of this disclosure will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings. Understanding that these drawings depict only several embodiments in accordance with the disclosure and are, therefore, not to be considered limiting of its scope, the disclosure will be described with additional specificity and detail through use of the accompanying drawings, in which:
  • FIG. 1A is a depiction of the method of determining the muscle fatigue onset index (MFOI) conversion factor from the regular time interval graph.
  • FIG. 1B is a depiction of sEMG data taken at regular intervals on a MPF vs. time.
  • FIG. 2A is a depiction of the method of determining MFOI conversion factor with data taken continuously and fitting a line to maximum amplitudes recorded.
  • FIG. 2B is a depiction of sEMG data taken continuously, with the maximum amplitudes recorded and fitted to a line.
  • FIG. 3A is a depiction of the method of determining MFOI conversion factor with data taken continuously and fitting a line to the average amplitudes recorded per interval of time.
  • FIG. 3B is a depiction of sEMG data taken continuously, with the average amplitudes per interval of time recorded and fitted to a line.
  • FIG. 4A is a depiction of the method for determining the chronic muscle overuse index (CMOI) conversion factor using amplitude values to aid the subject in preventing injury by estimating a time beyond which it is more likely for a subject to experience an injury.
  • FIG. 4B is a depiction of sEMG data gathered to determine the CMOI conversion factor for a new subject on an amplitude vs. time graph with the maximum and minimum noted.
  • FIG. 4C is a depiction of the amplitude vs. time data for the average subject based on the related average dataset similar to the data gathered for the new subject, which when compared to the new subject data is used to create the CMOI conversion factor.
  • FIG. 4D is a depiction of estimated amplitude vs. time data based on the application of the CMOI conversion factor to the recorded new subject data.
  • FIG. 5A is a depiction of the method for determining the CMOI conversion factor using mean power frequency (MPF) values to aid the subject in preventing injury by estimating a time beyond which it is more likely for a subject to experience an injury.
  • FIG. 5B is a depiction of MPF vs. time data for the average subject based on the related average dataset similar to the data gathered for the new subject, which when compared to the new subject data is used to create the CMOI conversion factor. FIG. 5D is a depiction of the rate of change for non-ideal conditions on the MPF vs. time graph.
  • FIG. 5C is a depiction of MPF vs. time data for the average subject based on the related average dataset similar to the data gathered for the new subject, which when compared to the new subject data is used to create the CMOI conversion factor.
  • FIG. 5D is a depiction of the rate of change for non-ideal conditions on the MPF vs. time graph.
  • FIG. 5E is a depiction of the rate of change for ideal conditions on the MPF vs. time graph.
  • FIG. 5F is a depiction of the MPF vs. time graph used to determine an estimated time to muscle exhaustion based on the application of the frequency based CMOI conversion factor to the new subject data.
  • FIG. 5G is a depiction of the rate of change for non-ideal conditions on the amplitude vs. time graph for determining the amplitude based CMOI conversion factor.
  • FIG. 5H is a depiction of the rate of change for non-ideal conditions on the amplitude vs. time graph used to determine a conversion factor and estimated time to muscle exhaustion based on the application to the new subject data.
  • FIG. 5I is a depiction of the method for determining the estimated time to muscle exhaustion based on the relationship between the actual rate of change observed and the rate of change of the related average dataset.
  • FIG. 5J is a depiction of the amplitude vs. time graph and the safety zones developed from the data gathered in the amplitude based CMOI method to aid the subject in preventing injury.
  • FIG. 5K is a depiction of the MPF vs. time graph and the safety zones developed from the data gathered in the frequency based CMOI method to aid the subject in preventing injury.
  • FIG. 6 is a depiction of a computing system that, in one embodiment, may be used to perform the methods disclosed herein.
  • FIG. 7A is a depiction of the amplitude vs. time graph where the peak amplitude of the new subject data is used to determine a first warm-up indicator in creating.
  • FIG. 7B is a depiction of the MPF vs. time graph where the point corresponding to the indicator shown in FIG. 7A is noted.
  • FIG. 7C is a depiction of the amplitude vs. time graph where the first warm-up indicator is noted, as well as the amplitude corresponding to a time based warm-up indicator and average subject input, both being based on a related average dataset.
  • FIG. 7D is a depiction of the MPF vs. time graph where the points corresponding to the indicators shown in FIG. 7C are noted.
  • FIG. 7E is a depiction of the subject-amplitude method of determining a new subject warm-up indicator based on new subject data and a related average dataset.
  • FIG. 7F is a depiction of the subject-frequency method of determining a new subject warm-up indicator based on new subject data and a related average dataset.
  • FIG. 8A is a depiction of the current state of the art for measuring maximum voluntary control MVC in a controlled environment and a part of the combined database used to determine the impulsive muscle overuse index (IMOI) conversion factor.
  • FIG. 8B is a depiction of the system data-gathering pseudo maximum voluntary control (PMVC) measurement in a semi-controlled environment.
  • FIG. 8C is a depiction of the method for producing a new subject IMOI, or an MVC estimate, using the PMVC.
  • FIG. 9A is a depiction of a system for measuring and estimating work for various activities using the Muscle Work Estimation Index (MWEI) conversion factor.
  • FIG. 9B is a depiction of the amplitude vs. time graph of the data gathered for the new subject activity to be used in creating an MWEI conversion factor.
  • FIG. 9C is a depiction of the work vs. time graph of the data gathered for the new subject activity to be used in creating an MWEI conversion factor.
  • FIG. 9D is a depiction of an integral of the amplitude vs. time graph for a related average dataset, where the area under the curve is useful in calculating the MWEI conversion factor for a given activity.
  • FIG. 9E is a depiction of an integral of the amplitude vs. time graph of new subject data, where the area under the curve is useful in calculating the MWEI conversion factor for any given activity.
  • FIG. 10A is a depiction of the sEMG data displayed on an amplitude vs. time graph useful in determining the slow-twitch muscle index (STMI) conversion factor, and the fast-twitch muscle index (FTMI) conversion factor, noting points including an inflection point before which fast-twitch fibers dominate the activity and after which slow-twitch fibers dominate the activity.
  • FIG. 10B is a depiction of the MPF vs. time graph noting points from FIG. 10A and their corresponding points on the MPF vs. time graph.
  • FIG. 10C is a depiction of the amplitude vs. time graph where a buffer range is optionally used to account for errors in determining the inflection point.
  • FIG. 11A is a depiction of the rate of change of an individual's personal mutli-dimensional fitness index (PMFI) index over time.
  • FIG. 11B is a depiction of the rate of change of one individual's PMFI over time compared to another individual's PMFI index over time.
  • These figures are arranged in accordance with at least one of the embodiments described herein, and which arrangement may be modified in accordance with the disclosure provided herein by one of ordinary skill in the art.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • In the following detailed description, reference is made to the accompanying drawings, which form a part hereof. In the drawings, similar symbols typically identify similar components, unless context dictates otherwise. The illustrative embodiments described in the detailed description, drawings, and claims are not meant to be limiting. Other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the subject matter presented herein. It will be readily understood that the aspects of the present disclosure, as generally described herein, and illustrated in the figures, can be arranged, substituted, combined, separated, and designed in a wide variety of different configurations, all of which are explicitly contemplated herein.
  • Generally, the present invention relates to systems and methods of implementing the assessment of muscle activation and performance by analyzing muscle data with algorithms and metrics. The term “subject” includes a user such as physical fitness consumer. The method can be utilized by a user to determine metrics useful in understanding the fitness of the user's own body alone, as compared to other user's metrics, and/or as compared to an average user's related metrics. There is described herein systems and methods including a computing system to gather a dataset of subject (e.g., a user of the system or method) who is engaged in an activity. The user's dataset is gathered, in part, from one or more of sensors or data gathering devices including: a surface electromyometry (sEMG) sensor attached to the skin of the user, temperature sensors attached to the user, heart rate sensors attached to the user, and the like. Each sensor or data gathering device is operably coupled to the computing system. The computing system then selects one or more muscle assessment protocols as directed by the user, automatically as determined by a predetermined decision, or even by a third party. The protocols selected will then configure the data necessary to properly determine the metric for the user engaged the activity, tailored for the activity, and the user. The metrics allow the user, or other third party, to assessing any of the following such as: the user's muscle condition, the user's muscle activity, a related average dataset based on average user's referenced in a database, projected estimates for the user's activity, and the like.
  • The computing system monitors and/or records relevant data of the users engaged in the activity. The computing system may also concurrently, or subsequently, monitor the data of other users engaged in the activity. Some metrics require a calibration period be used to gather data at ideal conditions for the user. In one embodiment, an ideal condition may be a 0° incline as opposed to a non-ideal condition such as a non-0° incline. The resulting metrics determine and assess the user's muscle activity as described above, but also are useful in determining a conversion factor to apply new estimates for activities performed under non-ideal conditions.
  • Often, the muscle data is provided as sEMG data, which can be processed by various algorithms in order to obtain metrics related to muscle activation and performance. The systems and methods can be designed to automatically calculate the metrics by sensors, processors, and computer-readable mediums. The systems can include hardware and software configured to perform the steps of the method described herein. For this invention, RMS amplitude can be described as an algorithm that is used to “rectify” a sEMG signal. If RMS is calculated, every data point (e.g., no “down sampling”) effectively yields the absolute value of the incoming data points. The RMS amplitude, is a useful way of interpreting sEMG data coming from muscles. RMS can be used for many other kinds of interpretive analyses that may be performed with sEMG data. For instance, the average rectified value over a period of time can be calculated based on RMS data instead of using raw or raw and filtered data. RMS can also be used for the following amplitude based metrics described herein.
  • The methods of methods of implementing the assessment of muscle activation and performance can be performed with any subject. The subject can wear one or more sensors on one or more muscles that are going to be used during a muscle activity, where the sensors may or may not be operably coupled to a computing device that is also worn by the subject during the muscle activity. This computing device may record muscle data during the muscle activity, and it may also even have wireless access to a network and may be able to record the data on a server or database in real time. Additionally, the computing device that is capable of accessing a remote server or database over a network may be able to access muscle data or muscle activity metrics of other subjects that have performed a substantially similar muscle activity. The similarity of muscle activities can arise by the muscle activities being part of a predetermined muscle activity, which allows for comparison of muscle data and metrics across one or more populations of subjects. The other subjects can be filtered for physiological condition, size, weight, age or the like with respect to the subject that is primarily performing the muscle activity. The muscle data or metrics can be compared in real time with information provided to the subject engaged in the muscle activity on the fly, or the data and metrics can be saved and the comparison can be done with a computing system after completion of the predetermined muscle activity. The database may also be accessed for muscle data and metrics for the same subject so that they can compare the activation and function of a current predetermined activity with a past implementation of the predetermined activity.
  • The ability to access muscle data and metrics from a database can allow for the subject to statistically generate estimates of the muscle data and metrics that is useful for determining muscle condition. In general, the comparison between data gathered for the new subject and a related average dataset is used to generate a conversion factor. The conversion factor is useful in generating a number of different metrics as will be shown below. First, the computing device can gather a dataset for a new subject. This dataset can include both the new subject's primary sEMG data, such as the amplitude of the sEMG graph, the mean power frequency (MPF), the maximum voluntary contraction (MVC), the heart rate (HR), the temperature of the subject, and secondary data such as height, weight, type of activity, and the like. Once the data has been gathered for the new subject, the data can be plotted on a graph representing the new subject's current data. The computing device can then reference the database to determine a related average dataset. A related average dataset can be created from referencing a large number of statistically significant past measurements for other subjects. It is important to note that the related average dataset can account for the secondary data as well as primary data. The related average dataset may even be a prior implementation of the muscle activity of the same subject. The computing system can then determine a conversion factor based on the relationship of the new subject data to the related average dataset.
  • A conversion factor can provide information about the relationship of the subjects muscle condition compared to the other subjects muscle condition. A conversion factor can be determined for different metrics, alone or in combination, useful in analyzing the new subject's muscle activity and overall fitness level. The method for determining a conversion factor can be illustrated below.
  • In the descriptions of the embodiments below, the methods described herein can be used to perform useful estimations of muscle health, muscle condition, caloric burn, work performed, safety estimations, and the like. Frequently, the example of running is used. However, it should be understood that these indexes and algorithms can be applied to continuous muscle activities (e.g., bicycling, swimming, cycling, and the like) or noncontinuous muscle activities (e.g., weight-lifting), as well as any number of other muscle activities that are conducive to sEMG-based analysis, which can be any static or dynamic muscle activity.
  • Muscle Fatigue Onset Index (MFOI)
  • The mean power frequency (MPF) can represent an average activation frequency of a muscular contraction, which can be measured during a short time period. Generally, the MFOI describes the rate of change of the MPF over a period of time. It has been shown that as a muscle becomes fatigued, the MPF decreases. However, the MPF alone may not be useful to a subject, and may not help the subject determine how “fit” their muscles are. This can be applied to overall condition of the muscles, not just how strong the muscles are, but more importantly the rate of change of the fatigue onset in their muscles. MFOI can be described as the average rate at which a muscle becomes fatigued. The MFOI and the MFOI conversion factor are muscle metrics that can be provided to individuals to assist in enhanced training for improvement of physical activities.
  • Thus, the MFOI is determined through MFOI protocol by selecting the MFOI protocol. As data is gathered, the MFOI protocol will configure data relevant to the MFOI metric such as the MPF, and duration. The data for MFOI can be gathered by measurements at set time intervals, continuously measuring peak amplitudes, continuously measuring average amplitudes, and the like. As the data is plotted to an MPF versus time graph, the slope of the line fitted to the data will determine the MFOI.
  • For example, a marathon runner who is in excellent shape may experience a very slow rate of muscle fatigue onset. On the other hand, an individual who is not in shape in terms of their muscular condition may experience a rapid rate of fatigue onset. The MFOI can allow for an easily comparable metric across individuals and populations that describe how quickly an average individuals' muscles become fatigued, and the MFOI conversion factor can allow for a new subject to estimate how quickly the new subject's muscles will become fatigued. Therefore MFOI and the MFOI conversion factor can be an important consideration for how “fit” the individual is.
  • The sensors worn by the subject can measure muscle data and determine metrics related to muscle activation and function. As such, various variables can be determined for the MFOI and the MFOI conversion factor. The frequency sampling rate (FSR) is an example of one variable in an algorithm for determining the MFOI and the MFOI conversion factor. The total length of time of the activity (AT) is another second variable. The quantity of total samples can be defined by Equation 1.

  • QS=(AT/FSR)+1  Equation 1
  • FIG. 1A depicts a general method 150 of muscle assessment that can be used in determining the MFOI and the MFOI conversion factor. The method 150 can include: gathering MPF values for a subject engaging in a certain activity (block 151); plotting MPF values on a graph allowing for a line to be fitted to the plotted points (block 152); and determining the slope of the line, where the slope is the MFOI (block 153). The amplitudes of the movements are identified automatically by the computing device for each regular time interval from data obtained from the sensors associated with the muscles. The computing device can utilize hardware (e.g., processors) and software on computer-readable mediums configured to carry out the steps of the method 150 reflected in FIG. 1A, which can be implemented for determining MFOI and the MFOI conversion factor. When this data is compared to data in a database, an average MFOI associated with a related average dataset is determined. The MFOI conversion factor is determined by dividing the MFOI (block 153) by the average MFOI. The MFOI conversion factor is useful in assessing muscle fatigue onset of one subject compared to an average subject, and can estimate amplitudes over time for that subject.
  • For example, if an individual runs for 30 minutes, and the computing device samples MPF every 5 minutes, then 7 samples are taken (t=0, t=5, t=10, t=15, t=20, t=25, t=30) as shown in FIG. 1B. These 7 data points, which include a time-stamp as well as an associated MPF, can then be fit with a curve using one of a number of standard methods (e.g., linear, polynomial curves, etc.). As in FIG. 1B, for a simplest best-use scenario, a line can be fitted to the data points. Typically, a line is represented by the well-known equation of y=mx+b, where the variable “m” represents the slope of the line, and thus the MFOI. In FIG. 1, the line representing the plotted data, can have a non-positive slope. The slope of the line can be thought of as MFOI, which describes the subject's average rate of change of the MPF over time.
  • Another implementation of MFOI can be performed in which for regular periodic movement (e.g., such as running, bicycling, swimming, or weightlifting) the peak amplitudes of these regular movements are identified automatically by the computing device from data obtained from the sensors associated with the muscles. The computing device can utilize hardware (e.g., processors) and software on computer-readable mediums configured to carry out the steps of the method 250 reflected in FIG. 2A, which can be implemented for determining MFOI with periodic movement data and peak amplitudes. In the method 250: the MPF values at peak amplitudes are gathered for a subject engaging in a certain activity (block 251); a graph is generated and a line is fit according to the MPF values at peak amplitudes (block 252); and the slope of the line is taken resulting in MFOI (block 253). The graph and line thereof are illustrated in FIG. 2B.
  • Another implementation for obtaining MFOI and the MFOI conversion factor can be performed in which for regular periodic movement (e.g., such as running, bicycling, swimming, or weightlifting) the averaged MPF in pre-set epochs can be used compared with FSR in which periodic samples are taken from a larger data set. This can be conducted in a method 350 for determining a subject's average MFOI and the MFOI conversion factor with periodic movement, which is illustrated in FIG. 3A. In the method 350: the average MPF amplitudes are gathered for a subject engaging in a certain activity for certain epochs (block 351; a graph is generated and a line is fit according to MPF values at average amplitudes (block 352); and the slope of the line is taken resulting in MFOI (block 353).
  • For all of the aforementioned methods, the MFOI conversion factor may be determined by referencing a database to determine a related average dataset. Thus, the method for determining the MFOI conversion factor for the method 250 and the method 350 is the same as the method for determining the MFOI conversion factor described above in method 150.
  • In general, the conversion factor is determined by a computing device gathering a dataset for a new subject. Once data has been gathered, a graph is generated and a line or a curve is fit according the data associated with each metric. Significant data values can be derived from the graph. In some metrics, such as MFOI, the significant data value is the slope of the line. In other metrics, significant data values may be the initial maximum amplitude, the final amplitude, the difference between the values, the work done by the activity, the temperature of the subject, the heart rate of the subject, the maximum voluntary contraction, the median power frequency, the mean frequency, any combination of the aforementioned values, and the like. Once significant values are determined, a database is referenced that determines a related average dataset. The conversion factor is based on the relationship between a subject's dataset and a related average dataset. In general, a conversion factor can be associated with any of the following, or aforementioned, metrics to assess muscular activity, alone or in combination.
  • The MFOI methods include the utilization of the MPF. Additionally, the MFOI can include the MPF in conjunction with amplitude values (e.g., combination terms which take the amplitude, and then add a term which utilizes the MPF or rate of change of the MPF). So if the amplitude is A, and the rate of change of the MPF is R, then the term for the combination method could be: A*c1+R*c2, where c1 and c2 are constants determined through database comparison or through past data recorded from the user, or a combination of both.
  • Additionally, in MFOI another embodiment can include taking particular slices of the frequency spectrum, and use those slices in the calculation of the MPF. This can be done instead of taking the whole frequency range to produce the MPF. For instance, if measuring from 50-500 Hz for sEMG, the MPF can be calculated based only upon 80 Hz-150 Hz. Alternatively, it can be calculated based on two regions (e.g., 20-40 Hz and 80-150 Hz), where each MPF calculation from each frequency range is multiplied by a constant which assigns significance. Other manipulations to frequency domain can be performed to produce more complex versions of a frequency characterization.
  • Chronic Muscle Overuse Index (CMOI)
  • It is known that exercising or engaging in a physical activity when an individual's muscles are fatigued can contribute to injury. It is also known that there are a number of different variables (e.g., individual physiological characteristics) that contribute to the rate of muscular fatigue onset, such as muscle length, local chemical characteristics, conduction velocity, and how “in shape” the individual is. In order to take these known variables, and use them in a way that can help prevent injury, a chronic muscle overuse index (CMOI). There are at least two categories of algorithmic protocols which may be used to determine a CMOI: amplitude-based CMOI calculation, and frequency-based CMOI calculation. In the following examples, calculations of CMOI will be performed for distance-running types of exercise; however other continuous or noncontinuous muscle activities can be performed for an CMOI protocol.
  • CMOI protocol can include an initial calibration where the user engages in an activity under ideal conditions. As data is gathered, the CMOI protocol will configure data relevant to the CMOI metric such as the sEMG amplitude, sEMG MPF, and duration. CMOI can be calculated by either the amplitude data gathered or by MPF data gathered. The data is plotted to either amplitude versus time graph, or MPF versus time graph. The CMOI protocol determines an average related dataset by referencing a database of other average users. CMOI is then developed based on the relationship between the dataset and the related average dataset. Finally, a conversion factor is found to determine CMOI for a non-ideal condition.
  • In an example of amplitude-based CMOI and CMOI conversion factor calculation, a new subject first conducts a safe calibration run for a short time at a slow/moderate speed in a controlled environment (e.g., for example: treadmill, 15:00 minutes, 4.0 mph, 0° incline). A method 450 of calculating an amplitude-based CMOI is illustrated in FIG. 4A. Initially, secondary subject data are gathered prior to or during a calibration run (block 451). The new subject performs a calibration run during which maximum and minimum amplitude data is gathered (block 452). The data is then referenced with respect to similar data of a database to establish a related average dataset (block 453). The CMOI is calculated based on similarities of the new subject data collected during the calibration run compared to the related average dataset (block 454). This CMOI helps to estimate the time to exhaustion the new subject will experience for subsequent runs. However, this can be performed for any muscle activity.
  • FIG. 4B graphically shows how the calculations are performed. The amplitude high-point for this segment is recorded as H0, the low-point is saved as L0, and the difference between the two is assigned to Δ1. Next, a database is referenced with respect to similar data including primary and secondary data such as demographics (e.g., subject age, height, weight, activity type, muscle in question) to obtain a similar CMOI and/or similar Δ1. As shown graphically in FIG. 4C, the database returns a number of datasets (e.g., at least 35 datasets for statistical significance), which together produce a number of average values: H (average) 411, L 1(average) 413, Δ 1(average) 415, Δ 2(average) 417, L 2(average) 419, T 2(average) 421. H (average) 411 is the average high-point amplitude of subjects in the database. L 1(average) 413 is the average low-point amplitude of subjects in the database. Δ 1(average) 415 is the difference between H (average) 411 and L 1(average) 413. T 2(average) 421 is the time at which subjects in the database experience perceived muscular exhaustion, and/or observable loss of coordination. Likewise, L 2(average) 419 is the amplitude at which subjects in the database experienced perceived muscular exhaustion, and/or observable loss of coordination. Δ 2(average) 417 is the difference between H (average) 411 and L 2(average) 419.
  • Then as shown in FIG. 4D, L2(estimated) 431 is calculated by Equation 2.

  • L 2(estimated) =H 0−Δ2(average)  Equation 2
  • T2(estimated) 433 is also calculated by Equation 3.

  • T 2(estimated) =T 2(average)=((Σn=0 n T 2)/n)  Equation 3
  • In a frequency-based CMOI calculation, a new subject first conducts a safe calibration run for a short time at a slow/moderate speed in a controlled environment (for example: treadmill, 15:00 minutes, 4.0 mph, 0° incline). A muscle assessment method 550 can be conducted as described in order to determine a CMOI, which method is shown in FIG. 5A. The secondary new subject data is gathered such as subject age, height, weight, activity type, or the like (block 552). The new subject primary data, including maximum and minimum MPF data, is gathered during a calibration activity (block 554). The database for the muscle activity is referenced to identify and/or obtain data for others that have similar demographics and/or similar CMOI in order to establish a related average dataset (block 555). The estimated time to muscle exhaustion is produced based on the corresponding similarities of new subject data and the related average dataset (block 558).
  • The data obtained during the method 550 can be used to produce the CMOI frequency based metrics that are graphically represented in FIGS. 5B-5E. As shown in FIG. 5B, the calibration run produces the maximum frequency (MPFi) 501, a final/minimum frequency (MPFf) 503, the difference between the MPFi and the MPFf 2) 505, the time change (Δt) 507, and the MFOI 509 represented by the MFOI equation 511.
  • As discussed above, the database is referenced to build an average dataset that is similar to the data gathered. The database returns some number of datasets (e.g., at least 35 data sets for statistical significance). As shown in FIG. 5C, the database referencing produces a number of average values: MPF i(average) 521, MPF f1(average) 523, Δ 1(average) 525, MPF f2(average) 527, T 2(average) 529, Δ2(average) 531.
  • MPF i(average) 521 is the average high-point MPF of subjects in the database. MPF f1(average) 523 is the average low-point MPF of subjects in the database. Δ 1(average) 525 is the difference between MPF i(average) 521 and MPF f1(average) 523. T 2(average) 529 is the time at which subjects in the database experience perceived muscular exhaustion, and/or observable loss of coordination. Likewise, MPF f2(average) 527 is the amplitude at which subjects in the database experienced perceived muscular exhaustion, and/or observable loss of coordination. Δ2(average) 531 is the difference between MPF i(average) 521 and MPF f2(average) 527.
  • Turning to FIG. 5F, MPF2(estimated) 541 is then calculated for the new subject. MPF2(estimated) 541 is the estimated MPF at which the new subject will experience muscular exhaustion, and is calculated by Equation 4. In Equation 4, T2 is the time associated with an individual subject entry in the database.

  • MPF 2(estimated) =MPF 1−Δ2(average)  Equation 4
  • T 2(estimated) 543, the estimated time to new subject exhaustion, is defined by Equation 5.

  • T 2(estimated) =T 2(average)=((Σn=0 n T 2)/n)  Equation 5
  • Subsequently, with any amplitude an observed rate of change can be calculated, and a CMOI conversion factor can be calculated. This rate of change can then be used to calculate times to exhaustion for subsequent activities of the same subject, even under differing conditions. For instance, as shown in FIGS. 5G and 5H for amplitude data, the observed rate of change can be observed for either a 0° incline or a non-0° incline, allowing for a conversion factor to be generated. This conversion factor can be adjusted for variables in the physical environment, which cause the subject to fatigue faster than expected. One method of doing this is based on the observed rate of change (ROC) of amplitude. For example, the rate of change on a non-0° incline ROCactual, which when divided by the observed rate of change of amplitude ROC0° (for 0° incline), produces the desired conversion factor. This conversion factor can be regularly recalculated by Equation 6.

  • Conversion Factor=ROCactual/ROC0°  Equation 6
  • From there, the estimated time of exhaustion may be calculated from the information previously provided by the related average dataset, and as explained when calculating the safety zones discussed below.
  • In both the amplitude-based, and the frequency-based calculation, “safety zones” can be established using the amplitude or MPF ranges for each zone, and the times associated with the boundaries for each zone. These zones can be visualization aids and are, in one embodiment, displayed on a graphical subject interface, and essentially break down the MPF range (from T=0 until final average MPF at the exhaustion point for the relevant database subset that is returned) into a number of easy-to-visualize categories. The method for creating these zones is explained shown in FIG. 5I. The relevant data is gathered by measuring maximum values (block 551). The database is referenced with respect to similar data to establish a related average dataset (block 553). The actual rate of change is divided by the related average dataset rate of change to establish a conversion factor (block 555). Safety zones are calculated based on the conversion factor as input (block 557). In addition, because these estimated zones are associated with either an amplitude or a frequency, the corresponding times can be calculated for these times zones. These visualization aids essentially break down the amplitude range (e.g., from start until final average amplitude at the exhaustion point for the relevant database subset that is returned) into a number of easy-to-visualize categories. In one embodiment, this may be done in a color code that is intuitive to subjects, such as Green, Yellow, Orange, and Red.
  • For an amplitude based calculation shown in FIG. 5J, the Green Zone can begin at H 0 571 and continues until, but not including, H 1 572 calculated by Equation 7.

  • H 1 =[H 0−(H 0 −L 2(estimated))/3]  Equation 7
  • The Yellow Zone begins at H 1 572, but not including and continues until, but not including, H 2 573 calculated by Equation 8.

  • H 2 =[H 1−(2*(H 0 −L 2(estimated))/3)]  Equation 8
  • The Orange Zone begins at H 2 573 and continues until, but not including, L 2(estimated) 574 as calculated by the equation listed above in Equation 2. It should be noted that the present invention contemplates a plurality of zones as required by the subject represented by Equation 9.

  • H (n+1) =[H n−((n+1)*(H 0 −L 2(estimated))/3)]  Equation 9
  • The Red Zone is any amplitude greater than or equal to L 2(estimated) 574. Finally, these amplitude divisions corresponding to safety zones may be converted to estimate times for each zone.
  • For an MPF based calculation shown in FIG. 5K, the Green Zone begins at MPF i 580 and continues until, but not including, MPF 1 581 calculated by Equation 10.

  • MPF 1 =[MPF i−(MPF i −MPF 2(estimated))/3]  Equation 10
  • The Yellow Zone begins at MPF 1 581 and continues until, but not including, MPF 2 582 calculated by Equation 10a.

  • MPF 2 =[MPF 1−(2*(MPF i −MPF 2(estimated))/3)]  Equation 10a
  • The Orange Zone begins at MPF 2 582 and continues until, but not including, MPF 2(estimated) 583 calculated by Equation 2. It should be noted that the present invention contemplates a plurality of zones as required by the subject represented by Equation 10b.

  • MPF (n+1) =[MPF n−((n+1)*(MPF i −MPF 2(estimated))/3)]  Equation 10b
  • Finally, these MPF divisions corresponding to safety zones may be converted to estimate times for each zone. Additionally, the estimated time of exhaustion, T2(estimated), may be calculated from the information provided from calculating the safety zones.
  • Like in the amplitude-based calculation, a conversion factor can be calculated for subsequent activities during a frequency-based calculation as in FIG. 5B and FIG. 5C. This conversion factor would adjust for variables in the physical environment which cause the subject to fatigue faster than expected. One method of doing this is based on the observed rate of change (ROC) of MPF, or aka the MFOI. For example, the rate of change on a non-0° incline ROCactual, which when divided by the observed rate of change of amplitude ROC(for 0° incline), produces the desired conversion factor. This conversion factor can be regularly recalculated by Equation 10c.

  • Conversion Factor=ROCactual/ROC  Equation 10c
  • Warm-Up Index (WUI)
  • Some athletes know the amount of time it takes them to warm up thoroughly based on years of trial and error experiences. However, the development of a warm-up index (WUI) can be used instead of the need for determination of this safety point through trial and error. While there are a multitude of factors that contribute to the length of time necessary to become warmed up, (e.g., including the muscles being exercised, general cardiovascular condition, etc.), the WUI should enable novice subjects to be better equipped to exercise and to understand their muscle response patterns more easily.
  • The WUI is derived from the method to develop CMOI. Thus, there are two general categories for determining the WUI: amplitude-based WUI, and frequency-based WUI Like the CMOI method, first, a calibration run is performed by the new subject, and the corresponding data recorded. Then, the maximum amplitude of the resulting amplitude vs. time curve can be used as a time corresponding to a first point of being warmed up as shown in FIG. 7A. The corresponding MPF associated with the time of the max amplitude can also be used as shown in FIG. 7B. Alternatively, as shown in FIGS. 7C and 7D, a database can be referenced through which some number of (e.g., at least 35) data subsets are analyzed, providing different available methods for establishing whether the subject is warmed up. The subjects in the database associated with subsets used can have similar characteristics to the new subject such as physical characteristics, similarities in recorded data or secondary metrics such as MFOI, or the like. When the dataset is created, a number of reference points are recorded for each type of data: the high-point amplitude and corresponding MPF, the amplitude corresponding to a time-based warm-up that is known to be effective based on the database results, for example, 10 minutes, and corresponding MPF for that time is a second warm-up point. In addition, the new subject can also reference the database referencing instead a subject-input experience marker where the subject's in the database feel warmed up and a corresponding time indicating a third warm-up point. Likewise, the subject can find the corresponding MPF associated with that subject-input experience time marker. In this way, an inexperienced subject can benefit from different available methods for establishing whether they are warmed up sufficiently.
  • Two general categories are described herein: amplitude-based WUI, and frequency-based WUI. In addition to these methods as discussed, the present invention can include a “work done” WUI, which simply sums up the amplitudes over time (e.g., the area under the graph, or integrated signal). The work done can be a simple sum of the RMS sEMG, or it can be FBAAR, or TBAAR (time-based amplitude adjusted). A given target warm-up value based on work done can be calculated the first time based on a database reference for users of similar age, height, weight, or the like. Subsequently, users can also establish time markers that set a work-done goal for the warm-up based on how they are feeling. Note that this is also related to the “Muscle Work Estimation Index.”
  • FIG. 7E depicts the method 770 of producing a new subject amplitude-based WUI. First, new subject secondary data is gathered during safety calibration activity (block 771). Second, new subject sEMG data is gathered for the new subject (block 772). Third, new subject sEMG amplitude data and secondary new subject data entered into a database (block 774). Fourth, the database is queried with respect to similar sEMG and secondary data to establish a related average dataset (block 776). Fifth, an estimated time to warm up is determined based on the subset's average time to warm up (block 778). The WUI conversion factor is determined by observing the relationship to the subject data and the average related dataset. Similar to other methods aforementioned, a WUI conversion factor can aid in estimating a warm-up time for a subject engaged in various activities.
  • FIG. 7F depicts a similar method 780 of producing a new subject estimate for WUI based on a frequency reading. First, new subject secondary data is gathered during safety calibration activity (block 781). Second, new subject sEMG data is gathered for the new subject (block 782). Third, new subject sEMG frequency data and secondary new subject data entered into a database (block 784). Fourth, the database is queried with respect to similar sEMG and secondary data to establish a related subset (block 786. Fifth, an estimated time to warm up is determined based on the subset's average time to warm up (block 788). Similar to the amplitude based WUI, the frequency based WUI conversion factor is determined by observing the relationship to the subject data and the average related dataset. Similar to other methods aforementioned, a WUI conversion factor can aid in estimating a warm-up time for a subject engaged in various activities.
  • Although two different methods are presented based on different data measurements, either method 770 or method 780 can be used to establish the WUI based on either related average subject data or related average subject direct input.
  • Impulsive Muscle Overuse Index (IMOI), Pseudo MVC (PMVC)
  • One important consideration when analyzing the amplitude of muscle sEMG signals in the context of athletics is whether the muscle being activated is within a reasonable safety range in terms of how much the muscle is being exerted with respect to its maximum voluntary contraction. Maximum voluntary contraction (MVC) is an established metric that describes the maximum amount of force that a muscle can exert during voluntary isometric contraction, as shown in FIG. 8A. Although FIG. 8A shows one embodiment of a method 800 of obtaining a MVC reading as shown with wireless sensors 804 (e.g., sEMG sensor) that send the sEMG data 806 wirelessly to a computing device 808, it is contemplated by this invention that readings can be taken wirelessly, wired, or otherwise. The method 800 can be implemented during any type of muscle activity, such as weightlifting with a weight machine 802 as illustrated. “Impulsive overuse” defines a safety threshold in relation to the instantaneous force generated by a single muscle contraction. This threshold is typically established by means of calculation of the MVC of an individual. It is known that operating above MVC force levels is dangerous. Excessive muscular contraction force can result in muscle injury, tendon injury, etc. Because of this known danger, the IMOI is proposed as a metric to aid athletes.
  • Like other metrics aforementioned, IMOI is determined through IMOI protocol by selecting the IMOI protocol. IMOI requires an initial calibration where the user engages in an activity under a semi-controlled environment. As data is gathered, the IMOI protocol will configure data relevant to the IMOI metric such as pseudo MVC (PMVC) explained in detail below. IMOI is determined based on the association of PMVC with known MVC data to create a related average dataset. The IMOI protocol determines a safety force threshold on the basis of the related average dataset.
  • In order to obtain useful information, a database is needed which correlates MVC to two metrics. The first metric is called “Pseudo MVC” or PMVC, which like MVC is a metric describing force. The second metric is rectified sEMG, or sEMG amplitude data, which is measured at different force levels. This can include both PMVC and MVC. In contrast to MVC, PMVC is calculated by way of isometric activities performed in semi-controlled environmental conditions such as is shown in FIG. 8B. FIG. 8B shows a subject having a sensor 804 that provides sEMG 806 to a computing device 808 while the subject lifts free-weights 810. Whereas an MVC reading uses isometric activities performed in completely controlled conditions such the MVC reading depicted in FIG. 8A, PMVC is a method for taking readings in semi-controlled environments. For instance, if the weight of a subject is known, and the subject stands on “tip toes” for a time, then the force on each gastrocnemius muscle can be estimated. This is an oversimplified example of a PMVC activity. There are a number of different kinds of isometric activities which subjects can easily and quickly perform which generate estimated force values. During each PMVC and MVC activity in the database, the sEMG amplitude is recorded.
  • A method 820 for determining PMVC is depicted in FIG. 8C. First, secondary new subject data is gathered (block 822). Second, the sEMG amplitude data is gathered for the new subject and the PMVC semi-controlled activity (block 824). The first reference database is comprised of many data sets which include “real MVC” performed in a completely controlled environment, as well as a number of separate PMVC values. The sEMG amplitude is measured for both MVC and PMVC. When a new subject (e.g., who is not in the database) performs a PMVC-inducing activity such as in FIG. 8B, the database can be used to correlate the PMVC to MVCs for individuals who have similar physical properties. The third step of the method 820 is to reference the new subject data with a combined PMVC/MVC database to develop a related average dataset (block 826). After the related average dataset is produced, the next step is to estimate MVC for the semi-controlled PMVC activity based on the dataset (block 828). Direct mathematical conversion between PMVC and MVC (with a calculated and disclosed error range) is also possible, without consulting the database using a PMVC/MVC conversion factor. A PMVC/MVC conversion factor is determined by modeling or approximating the relationships found within the database between PMVC and MVC. Either way, with or without direct database access, when a new subject performs a PMVC activity, and their sEMG amplitude is recorded, the corresponding conversion factor between PMVC sEMG amplitude and MVC sEMG amplitude is used to convert the new subject's PMVC sEMG amplitude into estimated MVC sEMG amplitude. This estimated MVC sEMG amplitude which is based on PMVC sEMG levels, database comparison, and analysis produces an IMOI. IMOI is the sEMG amplitude level which corresponds to an estimated safety threshold due to impulsive or instantaneous overloading or overuse.
  • Further, if it is experimentally determined that for the sake of mitigation of liability that some percentage of MVC is the practical safety limit (for instance, 70% MVC) during any given activity, this can be calculated in the same manner as specified above. The method for calculating a new threshold based on a more conservative approach is outlined in FIG. 8C described above.
  • In summary, IMOI are calculated by way of the following algorithmic process: a) a new subject decides they would like to know their IMOI for a given muscle group; b) the subject must enter information about themselves such as height, weight, age, or the like into the system; c) the subject selects an appropriate PMVC activity, and performs the activity while recording sEMG amplitude; d) the database is called, and the subset corresponding to age, height, specific muscle being measured, PMVC activity type, etc. is referenced; e) for that database subset, the average sEMG amplitude observed during MVC is calculated; f) for that same database subset, the average sEMG amplitude for the PMVC activity type, and for that specific muscle, is calculated; and g) the conversion factor (CF) between PMVC and MVC for that subset is calculated by Equation 11.

  • CF=MVC/PMVC  Equation 11
  • It should be noted that CR is the conversion ratio calculated by Equation 12.

  • CR=A m(average) /A p(average)  Equation 12
  • The distinction here is between a ratio of force (CF) and a ratio of two amplitudes (CR).
  • Thus, the algorithm can include: h) the sEMG amplitude measured by the new subject (from step “c”) is multiplied by the conversion factor CF (step “g”). Assuming that the activity coordinators are comfortable with 100% MVC being the practical safety limit, this calculated value is the IMOI (e.g., measured in microvolts). This is the safety threshold. An embodiment of this metric can be used in a real time feedback device that notifies the subject when he/she is approaching the threshold.
  • Assuming that the activity coordinators are comfortable with some fixed percentage of MVC being the practical safety limit of an activity (for instance, 70% MVC), then the above-calculated IMOI value in step “h” is multiplied by the appropriate percentage (e.g., in this case, 0.7). Then, the resulting value (e.g., in microvolts) is the IMOI.
  • It may be advantageous to adjust for fatigue. The above assumes that all measurements are being made with equally fatigued muscles. It is known that when muscles are fatigued through use over time, the observed amplitude for a given activity will change.
  • Muscular Work Estimation Index (MWEI)
  • The work done during one or more isotonic contractions can be measured by an ergometer. In the past, this has been the only way for a subject to track or monitor the amount of work that they were doing during any given exercise. A new method of measuring work and receiving feedback can be performed by using work index that measures data provided by a subject engaged in an activity as in FIG. 9A. FIG. 9A illustrates a subject riding a bike 902 that has a work sensor 904 (e.g., work ergometer) while wearing a leg sensor 906. The sensors 904, 906 wirelessly communicate data 907 to a computing device 908. In order to calculate the muscular work estimation index (MWEI) and an MWEI conversion factor, a database is needed to correlate work done with the integral of a rectified sEMG graph (e.g., area under the curve of a rectified sEMG graph). The database can be built with subject information.
  • Like other metrics aforementioned, MWEI is determined through MWEI protocol by selecting the MWEI protocol. MWEI requires an initial calibration where the user engages in an activity under a semi-controlled environment. As data is gathered, the MWEI protocol will configure data relevant to the MWEI metric such as integrated sEMG amplitude and work output. MWEI is determined based on the association of sEMG amplitude data with work output data to create a related average dataset conversion factor. The MWEI protocol thus allows sEMG data to be converted to work done.
  • In order to build a database, each person whose data is entered into the database discloses secondary subject data such as age, height, weight, and a number of other physiological measurements which they either already know or which can be easily determined experimentally (e.g., such as measuring body mass index, BMI). Then, the subjects perform specified activities in a semi-controlled environment (e.g., rowing machine, stationary bike, treadmill, resistance training machine, or the like). In FIG. 9B sEMG amplitude is being measured the entire time that subjects are performing the activity. As depicted in FIG. 9C work done by the activity is also being recorded. Every incoming data point includes multiple dimensions, including sEMG amplitude for associated times, integrated sEMG from t=0 until t=final shown in FIG. 9D, and work done from t=0 until t=final as measured by the ergometer associated with the machine, are all recorded.
  • Integrated sEMG is shown by Equation 13.

  • t=0 t=final sEMG  Equation 13
  • Work done is shown by Equation 14.

  • Σt=0 t=final ergometer output  Equation 14
  • Then, the conversion factor between integrated sEMG and work done is calculated by dividing the calculated work done (e.g., from t=0 until t=final) by the area under the curve of the rectified sEMG graph (e.g., from t=0 until t=final) shown by Equation 15.
  • CF = ( t = 0 t = final ergometer output t = 0 t = final sEMG ) Equation 15
  • When a new subject performs an activity, such as in FIG. 9E, the new subject's integrated sEMG (e.g., from t=0 until t=present) is calculated. Then, the new subject's integrated sEMG is multiplied by the average conversion factor CFaverage associated with the data subset's corresponding to the new subject's data, yielding an estimated value describing the amount of work that was done by that particular muscle of the individual performing that particular activity. This value is the MWEI.
  • Thus, MWEI is determined by Equation 16.

  • MWEI=SEMG new subject *CF average  Equation 16
  • Skeletal Muscle Calorie Index (SMCI)
  • Currently, caloric expenditure is estimated by way of measuring an individual's heart rate (HR) and then using that measurement in a very general formula to determine caloric burn. However, calculating caloric expenditure based on heart rate is inherently crude estimation, and as such contains a high likelihood of error/inaccuracy for any given individual.
  • Each time a muscle contracts, there is an energy cost, as measured in calories. While heart rate is a relatively inexpensive estimation method (e.g., because heart rate monitors have become relatively inexpensive), it lacks accuracy and specificity based on muscle type, activity type, or the like.
  • A database can be used to provide a more robust estimate of caloric burn. This database can be multidimensional, and can be sorted by muscle, by activity, and by secondary factors such as: age of subject, BMI of subject, height of subject, as well as a number of other factors as mentioned in databases required for other methods/metrics listed herein. The function of this database is to correlate the caloric expenditure of certain activities with the area under the curve of the rectified sEMG graph recorded during those activities. The database can be created by performing activities that are “simple”: a single muscle performing a single action, while recording the caloric expenditure of that single action as well as the area under the rectified sEMG graph for that single action. The protocol can use the most accurate measures of caloric expenditure available. Namely, established methods can be used, such as in a controlled environment that measures the change in temperature of the subject to gauge caloric expenditure. There are several other methods available for this, none of which are central to the SMCI. Regardless of method, when a known caloric cost is associated with the area under a rectified sEMG graph, on a muscle-by-muscle basis, for individuals with similar physical characteristics, this relationship can be harnessed and conversion factors can be created.
  • Like other metrics aforementioned, SMCI is determined through SMCI protocol by selecting the SMCI protocol. SMCI requires an initial calibration where the user engages in an activity. As data is gathered, the SMCI protocol will configure data relevant to the SMCI metric such as integrated sEMG amplitude and caloric expenditure. SMCI is determined based on the association of sEMG amplitude data with caloric expenditure data to create a related average dataset conversion factor associating sEMG data with an average caloric burn. The SMCI protocol thus allows sEMG data to be converted to caloric expenditure. The SMCI can be used for a single muscle, or multiple muscle groups.
  • Once the data has been associated with a caloric burn, a conversion factor is created, including some additional steps. This is done by first creating a conversion factor associating the total number of calories burned with the area under the subject's rectified sEMG data curve for that particular muscle, represented by Equation 17:
  • CF = ( Total Calories Burned t = 0 t = final sEMG ) Equation 17
  • For multiple muscles or multiple muscle groups associated with the same activity, the conversion factor can be modified by Equation 18:
  • CF = ( Total Calories Burned t = 0 t = final sEMG ) Equation 18
  • When a new subject performs an activity while live rectified sEMG data is being recorded, the database is referenced, and the area under the subject's rectified sEMG data curve for that particular muscle, or multiple muscles/muscle groups be correlated with an associated caloric cost. Once the new subject's integral rectified of sEMG data has been converted to an associated caloric burn, the new subject's SMCI can be calculated.
  • SMCI is calculated by gathering a subset from the database based on data related to the new subject's data, producing a subset of a number of (e.g., at least 35) subjects in the subset, and a conversion factor for each. An average conversion factor is calculated by Equation 19:
  • CF subset average = ( n = 1 n = total CFn total ) Equation 19
  • Finally, the new subject's integral rectified sEMG data is converted to the new subject's SMCI by Equation 20:

  • SMCI=(Σ∫sEMGnew)×(CF related average dataset)  Equation 20
  • Thus, a SMCI can be tailored for the subject and for the activity. For any given activity, there are certain muscles which are primary contributors to the caloric cost of the activity. For instance, running and bicycling result in caloric expenditure that is primarily due to core muscle activation and lower extremity activation (e.g., gluteus muscles, leg muscles). Monitoring the sEMG output of these muscles will produce a more tailored estimate of caloric expenditure which uses the electrical output of the muscles to estimate caloric burn, instead of status-quo Heart Rate-only methods.
  • Cardio-Skeletal Muscle Calorie Index (CMCI)
  • The cardio-skeletal muscle calorie index (CMCI) is similar to the Skeletal Muscle Calorie Index. The major differentiating factor is that two databases are utilized, however, and they may be combined into a single database. Essentially, this is a combination index which utilizes previously established heart rate-only methods of caloric expenditure, and also estimates of calories burned based on the more accurate skeletal muscle calorie index as well.
  • Like other metrics aforementioned, CMCI is determined through CMCI protocol by selecting the CMCI protocol. CMCI requires an initial calibration where the user engages in an activity. As data is gathered, the CMCI protocol will configure data relevant to the CMCI metric such as integrated sEMG amplitude and heart rate (HR) data. CMCI is determined based on the association of sEMG amplitude data with HR data and a known HR caloric expenditure database to create a related average dataset conversion factor associating sEMG data with an average caloric expediture. The CMCI protocol thus allows sEMG data to be converted to caloric expenditure. The CMCI can optionally be calculated with weights on sEMG amplitude or HR caloric expenditure as determined to appropriate.
  • One description of a method to determine a CMCI would be as follows. An individual performs a muscle activity, and the HR and rectified sEMG data are both recorded for the duration of the activity. A previously established database determines the relationship between HR and calorie burn can be obtained or determined, producing an estimate of calories burned (CHR). The second database, such as the SMCI database expressed above, empirically establishes the conversion factor by the relationship between rectified sEMG data and calories burned using the area under the rectified sEMG curve, and produces a second estimate of calories burned (CRS). The CMCI is then calculated by Equation 21.

  • CMCLI 1=(0.5*CHR)+(0.5*CRS)  Equation 21
  • This equation expresses equal weights on each database, however, different weights can be assigned to either the CHR value or the CRS value depending on preference.
  • Muscle Activation Symmetry Index (MASI) and Normalized Muscle Activation Symmetry Index (NMASI)
  • Muscle activation refers to rectified sEMG amplitude. Symmetry refers to left-side and/or right-side muscles, such as the left quadriceps femoris and the right quadriceps femoris. “Normalized” refers to a database which describes normal variation in symmetry found in sEMG measurements during particular activities derived from a series of studies using statistically significant numbers of subjects. Symmetry in this context can refer to a logically grouped pair of muscles.
  • Instantaneous left-side amplitude (ILSA) is the rectified sEMG amplitude of a muscle on the left side of the body. Instantaneous right-side amplitude (IRSA) is the rectified sEMG amplitude of a muscle on the right side of the body. Thus, MASI is defined by Equation 22.

  • MASI=IRSA−ILSA  Equation 22
  • By setting a precedent that MASI is always calculated by subtracting the right side from the left side, the sign of the resulting MASI (+/−) becomes significant, and can quickly tell the subject which side of their body is exhibiting greater activation potentials, and what that difference is between those potentials.
  • Like other metrics aforementioned, MASI is determined through MASI protocol by selecting the MASI protocol. MASI requires an initial calibration where the user engages in an activity. As data is gathered, the MASI protocol will configure data relevant to the MASI metric such as rectified sEMG amplitude for the right and left side of a symmetrical muscle group. MASI is the difference between the right side and left side amplitude.
  • The difference index MASI, when compared to the normalized difference index NMASI, can help describe the manner an individual performs a certain type of physical activity. For example, if it is known that for 1000 subjects who have had the rectified sEMG amplitude of their left and right quadriceps femoris measured while swimming 100 meters, the average NMASI can be shown to be 50 microvolts, then this normalized difference index can be used when a new subject decides to swim 100 meters while measuring their sEMG amplitude. If the new subject's MASI is 30 microvolts, then they are within a normal difference index range for that muscle group, that activity, and that particular subset of subjects which correlate to the new subject's physical characteristics. In other words, if MASI<NMASI, the difference index is normal. If MASI>NMASI, difference index is not normal.
  • Lack of normality can indicate different situations. It could indicate a recruitment pattern (e.g., learned behavior) that is asymmetrical. If that is the case, then the individual would benefit from training and re-education. It could indicate that the subject has an injury on one side of their body, and is favoring the other side. If that is the case, then the subject should probably not yet be performing that activity (e.g., possibly because a subject is not fully recovered from injury yet). It could also indicate that one side of the subject's body is significantly stronger than the other side. If that is the case, then the subject should strengthen the side of their body that is weaker. Regardless, MASI versus NMASI is a valuable tool for individuals who perform physical activities that require equal force from both sides of their bodies.
  • It shall be appreciated that these comparisons can be done not only for instantaneous measurements but also for measurements taken over a period of time. This is accomplished by either taking the integral of the MASI readings for each symmetrical side of a muscle or muscle group, or by taking the average. The integral of MASI is defined by Equation 23.

  • MASI integral=∫t=0 t=n A:right−∫t=0 t=n A:left  Equation 23
  • MASI average is defined by the Equation 24

  • MASI average =A R(average) −A L(average)  Equation 24
  • Muscle Work Difference Index (MWDI) and Normalized Muscle Work Difference Index (NMWDI)
  • Muscle work difference index (MWDI) and normalized work difference index (NMWDI) are similar to MASI, but they differ from MASI in a few significant ways. The simplest way to clearly define MWDI or its counterpart NMWDI is to describe the difference between MASI and MWDI.
  • First, MASI only is used to describe left versus right side of the body, as measured only in a single muscle group. In contrast, MWDI may compare the difference between left versus right in a single group, but may also compare one muscle group to another. For instance, right biceps brachii can be compared to right triceps brachii during an isotonic machine bench-press. MWDI may also compare a work difference index for two individuals with the measurement being performed on exactly the same muscle. It may also be a work difference index for the same individual, and the same muscle, but on different days and/or at different times.
  • Second, MWDI utilizes muscular work estimation index (MWEI) explained above. MWDI is a comparison of work done, not of sEMG amplitude observed. While these are proportional, the difference observed is affected by the conversion factor used to convert between amplitude over time and/or area under the curve to work done. In this sense, since numbers describing work done are always larger than numbers describing instantaneous activation levels (e.g., an extra dimension of time is utilized, as well as the amplitude dimension) it is a more sensitive measurement. Additionally, this measure allows for more comparisons over time and a more complete understanding of how a muscle works.
  • Like other metrics aforementioned, MWDI is determined through MWDI protocol by selecting the MWDI protocol. The MWDI protocol in turn utilizes the MWEI protocol aforemention. The MWDI protocol determines at least a first value and a second value representing the work done for each muscle or muscle group measured. MWDI is the difference between the first value and the second value. This is useful when compared to past datasets, average datasets of the same user or average datasets for other users. An average dataset comparison is called the NWDI.
  • Thus, after a first related MWEI data set and a second related MWEI data set are created, the values are subtracted to determine MWDI. If MWDI<NMWDI, difference index is normal. If MWDI>NMWDI, difference index is not normal.
  • Slow-Twitch Muscle Indexes (STMI)
  • The slow-twitch muscle indexes (STMI) are a family of metrics that are extracted from a single calibration activity, not a database. STMI is derived from a method for graphical/analytical filtering (e.g., viewing only slow-twitch fiber activation) as well as a method for quantifying slow-twitch fiber activation in a variety of ways, including maximum amplitude of slow-twitch muscle fiber activation, average amplitude of slow-twitch muscle fiber activation, rate of fatigue of slow-twitch muscle fibers, length of time required before slow-twitch fibers become the primary force behind an activity, and work done by slow-twitch fibers during an activity.
  • Like other metrics aforementioned, STMI is determined through STMI protocol by selecting the STMI protocol. The STMI protocol gathers sEMG data and then measures the inflection point. The inflection point is determined on the graph of sEMG amplitude versus time or the corresponding MPF versus time. The inflection point represents the point at which fast-twitch muscle fibers become a secondary force to slow-twitch muscle fibers.
  • An individual who wishes to determine “how much” and “for how long” their slow-twitch muscle fibers activate during physical activity first applies sensors and/or devices for the measurement of sEMG amplitude and frequency. The individual then performs the activity, which is rate-controlled and exertion-controlled to the greatest extent possible. For example, if a runner wishes to determine their STMI, they might apply sensors, and then run on a treadmill for 30 minutes at 5.5 mph, with a fixed stride rate of 120 heel strikes per minute (hspm). As shown in FIG. 10A, the resultant sEMG amplitude graph is observed, and the inflection point between the initial rate of change decrease and secondary rate of change decrease is marked. In FIG. 10B, the graph of MPF versus time is superimposed on the graph of amplitude versus time, so that at the point of inflection noted, the MPF of that transition point can be likewise determined. Then, a band-pass filter is implemented retroactively on the graph, with the allowed frequency range being equal to or less than the MPF of the transition point. Since initially observed amplitudes and frequencies are due to fast-twitch fiber activation, and these fibers become relatively quickly fatigued, by filtering out the frequencies above the MPF of the transition point, the fast-twitch fibers are eliminated from the observed data.
  • For example, it has been experimentally observed that during a 30-minute run, initial sEMG amplitudes are significantly higher than later sEMG amplitudes. There are also two distinct drop-off rates. Initially, fast-twitch fibers dominate the observed amplitude signals. After roughly 12 minutes of running, amplitude drops severely, and frequency as decreased as the fast-twitch fibers have fatigued and slow-twitch fibers start to predominate the signal.
  • The following is an example of how this might manifest: Initial amplitude being 2000 microvolts (average); Initial MPF being 180 Hz; Inflection point time being 12 minutes; Inflection point amplitude being 800 microvolts; Inflection point frequency being 100 Hz; Final amplitude being 100 microvolts; Final MPF being 70 Hz; and/or STMI band-pass filter set-up being 5-100 Hz.
  • Looking only at Slow-Twitch Muscle Index (STMI), we now can start to calculate the following: Maximum amplitude of slow-twitch muscle fiber activation; Average amplitude of slow-twitch muscle fiber activation; Rate of fatigue of slow-twitch muscle fibers; The length of time required before slow-twitch fibers become the primary force behind an activity; and/or work done by slow-twitch fibers during an activity. The maximum amplitude of slow-twitch muscle fiber activation can include the maximum amplitude being the amplitude of the rectified sEMG graph at the inflection point. The average amplitude of slow-twitch muscle fiber activation can be the average amplitude of the rectified sEMG graph from the inflection point until the end of the session. The rate of fatigue of slow-twitch muscle fibers can be calculated by looking at the slope of a line, or rate of change, which is fit to the graph of MPF versus time, from the point of inflection until the final point, represented by Equation 25.

  • m=(Change in MPF)/(Change in time)  Equation 25
  • The change in time is the length of time required before slow-twitch fibers become the primary force behind an activity. This is the amount of time until the inflection point.
  • Work done by slow-twitch fibers during an activity can be calculated by taking the integral of the rectified sEMG graph, from the inflection point until the final point. Then, muscular work estimation index (MWEI) average conversion factor is utilized to convert area under the curve to work done by Equation 26.

  • Work Done by Slow-Twitch=MWEI slow-twitch =CF average*∫Time of Inflection Time of Final sEMG  Equation 26
  • The area under the curve of the rectified sEMG graph can also be converted to calories burned by the slow-twitch fibers by conversion through skeletal muscle calorie index (SMCI) database referencing, if desired. Finally, the STMI may be configured with a buffer range. A buffer range may be necessary in order to account for errors in the measurement as shown in FIG. 10C.
  • Fast-Twitch Muscle Index (FTMI)
  • The fast-twitch muscle index (FTMI) includes a family of indexes which are closely related to the STMIs; however, as expected, a band-pass filter is created for all data points after detection of the inflection point, rather than for all points before the inflection point in the STMI method.
  • Like other metrics aforementioned, FTMI is determined through FTMI protocol by selecting the FTMI protocol. The FTMI protocol gathers sEMG data and then measures the inflection point. The inflection point is determined on the graph of sEMG amplitude versus time or the corresponding MPF versus time. The inflection point represents the point at which fast-twitch muscle fibers become a secondary force to slow-twitch muscle fibers.
  • As shown in FIG. 10A, the maximum amplitude of fast-twitch muscle fiber activation is determined, which is the maximum amplitude of the rectified sEMG graph observed prior to the inflection point. It should be noted that the figures for the slow-twitch protocols can be used for fast-twitch protocols.
  • Also, an average amplitude of fast-twitch muscle fiber activation can be determined. This is the average amplitude of the rectified sEMG graph from the start of the session until the inflection. The rate of fatigue of fast-twitch muscle fibers can also be determined, which is calculated by looking at the slope of a line which is fit to the graph of MPF versus time, from the start point until the point of inflection as expressed in Equation 25 above. The work done by fast-twitch fibers during an activity can be calculated by taking the integral of the rectified sEMG graph, from the first point until the inflection point. Then, the MWEI and associated conversion factor, is utilized to convert area under the curve to work done as represented by Equation 27.

  • Work Done by Fast Twitch=MWEI fast-twitch =CF MWEI average×(∫Time of Start Time of Inflection sEMG)  Equation 27
  • Also, the area under the curve of the rectified sEMG graph can be converted to calories burned by the slow-twitch fibers by conversion through SMCI database referencing, if desired. Finally, the FTMI may be configured with a buffer range. A buffer range may be necessary in order to account for errors in the measurement.
  • Personal Multidimensional Fitness Index (PMFI)
  • The personal multidimensional fitness index (PMFI) is a mutli-factor metric which describes the fitness level of an individual at a particular point in time, as shown in FIG. 11A. In addition, PMFI can describe the fitness level of different individuals over time as shown by FIG. 11B. While there are many fitness metrics in use today, this metric differentiates itself by including sEMG-based factors such as the MFOI.
  • Like other metrics aforementioned, PMFI is determined through PMFI protocol by selecting the PMFI protocol. The PMFI protocol gathers data related to some of the aforementioned metrics, and aggregates the resultant values to create PMFI.
  • In order to calculate the PMFI, an individual can perform an activity for a length of time that is non-negligible (more than a few minutes). For example, in one embodiment, a runner might run for 30 minutes or whatever their typical exercise might be. In this manner, the MFOI is calculated, which has a negative value. The less in shape an individual's muscles are, more negative the MFOI becomes. The closer to 0 the slope of the graph of MPF over time is, the more in shape an individual's muscles are.
  • Another factor may be based on MASI. For the activity performed over a length of time, the symmetry index is also recorded (e.g., MASI). The closer MASI is to 0, the more in shape the subject is.
  • Likewise, the HR of the individual is measured during the activity. At a given age, each individual has a target HR for physical activity which involves a cardiovascular component (e.g., basically all physical activities). The closer to the target HR an individual is, the more in-shape they are, cardiovascularly speaking.
  • Also, the BMI of an individual can be utilized in the PMFI metric. It can be estimated in a number of ways, including a simplistic estimation based on the subject's height and weight. The closer to their ideal BMI a subject is, the more in-shape the subject is. In other words, the closer to zero the difference between ideal BMI and actual BMI is zero, the more in-shape the individual is.
  • Additionally, maximum oxygen consumption (e.g., VO2_max) can be utilized as well. This is a derivative metric, which can be estimated based on max HR during exercise. Since the ideal VO2_max for any individual can be determined by HR, the close to zero the difference is between ideal VO2_max and actual VO2_max, the more in-shape the individual is.
  • PMFI is calculated by Equation 28 or a normalized version thereof.

  • PMFI=n−{(|MFOI|+MASI+|(HR_ideal−HR_actual)|+|(BMI_ideal−BMI_actual)|+|(VO2Max_ideal−VO2Max_actual)|}  Equation 28
  • Here, “n” is a non-critical constant determined experimentally. Depending on natural variation in PMFI in a given population, “n” can be set to provide a spread with a range that is intuitive to subjects who wish to look at the number and quickly assess their personal fitness level. In the above PMFI definition, each term has been set up in such a way so that if the subject is in ideal shape, PMFI will be close in range to the constant “n.” Alternatively, if the subject is out of shape, PMFI will be comparatively far from the constant “n.”
  • In one embodiment, the invention described herein can be implemented with the sensors or systems described in U.S. Provisional Application Nos. 61/385,048 and 61/514,148 and U.S. patent application Ser. No. 13/239,033. Additionally, the invention described herein can be implemented with metrics and algorithms described in U.S. Provisional Application No. 61/385,046 and U.S. patent application Ser. No. 13/239,105. Also, the invention described herein can be implemented with methods of promoting fitness described in U.S. Provisional Application No. 61/385,053 and U.S. patent application Ser. No. 13/239,079. Further, the invention described herein can be implemented with graphing methods described in U.S. Provisional Application No. 61/385,049. Also, the invention described herein can be implemented with the multi-functional carrying case and associated biometric sensors and transceivers described in U.S. Provisional Application No. 61/385,051. The invention described herein can be implemented with the devices, systems, and/or methods described in U.S. Pat. Nos. 7,593,769 and 7,809,435. The patents and patent applications recited herein are incorporated herein by specific reference in their entirety.
  • One skilled in the art will appreciate that, for this and other processes and methods disclosed herein, the functions performed in the processes and methods may be implemented in differing order. Furthermore, the outlined steps and operations are only provided as examples, and some of the steps and operations may be optional, combined into fewer steps and operations, or expanded into additional steps and operations without detracting from the essence of the disclosed embodiments.
  • The present disclosure is not to be limited in terms of the particular embodiments described in this application, which are intended as illustrations of various aspects. Many modifications and variations can be made without departing from its spirit and scope, as will be apparent to those skilled in the art. Functionally equivalent methods and apparatuses within the scope of the disclosure, in addition to those enumerated herein, will be apparent to those skilled in the art from the foregoing descriptions. Such modifications and variations are intended to fall within the scope of the appended claims. The present disclosure is to be limited only by the terms of the appended claims, along with the full scope of equivalents to which such claims are entitled. It is to be understood that this disclosure is not limited to particular methods, reagents, compounds compositions or biological systems, which can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
  • In one embodiment, the present methods can include aspects performed on a computing system. As such, the computing system can include a memory device that has the computer-executable instructions for performing the method. The computer-executable instructions can be part of a computer program product that includes one or more algorithms for performing any of the methods of any of the claims.
  • In one embodiment, any of the operations, processes, methods, or steps described herein can be implemented as computer-readable instructions stored on a computer-readable medium. The computer-readable instructions can be executed by a processor of a wide range of computing systems from desktop computing systems, portable computing systems, tablet computing systems, hand-held computing systems and/or any other computing device.
  • There is little distinction left between hardware and software implementations of aspects of systems; the use of hardware or software is generally (but not always, in that in certain contexts the choice between hardware and software can become significant) a design choice representing cost vs. efficiency tradeoffs. There are various vehicles by which processes and/or systems and/or other technologies described herein can be effected (e.g., hardware, software, and/or firmware), and that the preferred vehicle will vary with the context in which the processes and/or systems and/or other technologies are deployed. For example, if an implementer determines that speed and accuracy are paramount, the implementer may opt for a mainly hardware and/or firmware vehicle; if flexibility is paramount, the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware.
  • The foregoing detailed description has set forth various embodiments of the processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. In one embodiment, several portions of the subject matter described herein may be implemented via Application Specific Integrated Circuits (ASICs), Field Programmable Gate Arrays (FPGAs), digital signal processors (DSPs), or other integrated formats. However, those skilled in the art will recognize that some aspects of the embodiments disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as a program product in a variety of forms, and that an illustrative embodiment of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution. Examples of a signal bearing medium include, but are not limited to, the following: a recordable type medium such as a floppy disk, a hard disk drive, a CD, a DVD, a digital tape, a computer memory, etc.; and a transmission type medium such as a digital and/or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link, etc.).
  • Those skilled in the art will recognize that it is common within the art to describe devices and/or processes in the fashion set forth herein, and thereafter use engineering practices to integrate such described devices and/or processes into data processing systems. That is, at least a portion of the devices and/or processes described herein can be integrated into a data processing system via a reasonable amount of experimentation. Those having skill in the art will recognize that a typical data processing system generally includes one or more of a system unit housing, a video display device, a memory such as volatile and non-volatile memory, processors such as microprocessors and digital signal processors, computational entities such as operating systems, drivers, graphical subject interfaces, and applications programs, one or more interaction devices, such as a touch pad or screen, and/or control systems including feedback loops and control motors (e.g., feedback for sensing position and/or velocity; control motors for moving and/or adjusting components and/or quantities). A typical data processing system may be implemented utilizing any suitable commercially available components, such as those generally found in data computing/communication and/or network computing/communication systems.
  • The herein described subject matter sometimes illustrates different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures can be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated can also be viewed as being “operably connected”, or “operably coupled”, to each other to achieve the desired functionality, and any two components capable of being so associated can also be viewed as being “operably couplable”, to each other to achieve the desired functionality. Specific examples of operably couplable include but are not limited to physically mateable and/or physically interacting components and/or wirelessly interactable and/or wirelessly interacting components and/or logically interacting and/or logically interactable components.
  • FIG. 6 shows an example computing device 600 that is arranged to perform any of the computing methods described herein. In a very basic configuration 602, computing device 600 generally includes one or more processors 604 and a system memory 606. A memory bus 608 may be used for communicating between processor 604 and system memory 606.
  • Depending on the desired configuration, processor 604 may be of any type including but not limited to a microprocessor (μP), a microcontroller (μC), a digital signal processor (DSP), or any combination thereof. Processor 604 may include one more levels of caching, such as a level one cache 610 and a level two cache 612, a processor core 614, and registers 616. An example processor core 614 may include an arithmetic logic unit (ALU), a floating point unit (FPU), a digital signal processing core (DSP Core), or any combination thereof. An example memory controller 618 may also be used with processor 604, or in some implementations memory controller 618 may be an internal part of processor 604.
  • Depending on the desired configuration, system memory 606 may be of any type including but not limited to volatile memory (such as RAM), non-volatile memory (such as ROM, flash memory, etc.) or any combination thereof. System memory 606 may include an operating system 620, one or more applications 622, and program data 624. Application 622 may include a determination application 626 that is arranged to perform the functions as described herein including those described with respect to methods described herein. Program Data 624 may include determination information 628 that may be useful for analyzing the contamination characteristics provided by the sensor unit 240. In some embodiments, application 622 may be arranged to operate with program data 624 on operating system 620 such that the work performed by untrusted computing nodes can be verified as described herein. This described basic configuration 602 is illustrated in FIG. 6 by those components within the inner dashed line.
  • Computing device 600 may have additional features or functionality, and additional interfaces to facilitate communications between basic configuration 602 and any required devices and interfaces. For example, a bus/interface controller 630 may be used to facilitate communications between basic configuration 602 and one or more data storage devices 632 via a storage interface bus 634. Data storage devices 632 may be removable storage devices 636, non-removable storage devices 638, or a combination thereof. Examples of removable storage and non-removable storage devices include magnetic disk devices such as flexible disk drives and hard-disk drives (HDD), optical disk drives such as compact disk (CD) drives or digital versatile disk (DVD) drives, solid state drives (SSD), and tape drives to name a few. Example computer storage media may include volatile and nonvolatile, removable and non-removable media implemented in any method or technology for storage of information, such as computer readable instructions, data structures, program modules, or other data.
  • System memory 606, removable storage devices 636 and non-removable storage devices 638 are examples of computer storage media. Computer storage media includes, but is not limited to, RAM, ROM, EEPROM, flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which may be used to store the desired information and which may be accessed by computing device 600. Any such computer storage media may be part of computing device 600.
  • Computing device 600 may also include an interface bus 640 for facilitating communication from various interface devices (e.g., output devices 642, peripheral interfaces 644, and communication devices 646) to basic configuration 602 via bus/interface controller 630. Example output devices 642 include a graphics processing unit 648 and an audio processing unit 650, which may be configured to communicate to various external devices such as a display or speakers via one or more A/V ports 652. Example peripheral interfaces 644 include a serial interface controller 654 or a parallel interface controller 656, which may be configured to communicate with external devices such as input devices (e.g., keyboard, mouse, pen, voice input device, touch input device, etc.) or other peripheral devices (e.g., printer, scanner, etc.) via one or more I/O ports 658. An example communication device 646 includes a network controller 660, which may be arranged to facilitate communications with one or more other computing devices 662 over a network communication link via one or more communication ports 664.
  • The network communication link may be one example of a communication media. Communication media may generally be embodied by computer readable instructions, data structures, program modules, or other data in a modulated data signal, such as a carrier wave or other transport mechanism, and may include any information delivery media. A “modulated data signal” may be a signal that has one or more of its characteristics set or changed in such a manner as to encode information in the signal. By way of example, and not limitation, communication media may include wired media such as a wired network or direct-wired connection, and wireless media such as acoustic, radio frequency (RF), microwave, infrared (IR) and other wireless media. The term computer readable media as used herein may include both storage media and communication media.
  • Computing device 600 may be implemented as a portion of a small-form factor portable (or mobile) electronic device such as a cell phone, a personal data assistant (PDA), a personal media player device, a wireless web-watch device, a personal headset device, an application specific device, or a hybrid device that include any of the above functions. Computing device 600 may also be implemented as a personal computer including both laptop computer and non-laptop computer configurations. The computing device 600 can also be any type of network computing device. The computing device 600 can also be an automated system as described herein.
  • The embodiments described herein may include the use of a special purpose or general-purpose computer including various computer hardware or software modules.
  • Embodiments within the scope of the present invention also include computer-readable media for carrying or having computer-executable instructions or data structures stored thereon. Such computer-readable media can be any available media that can be accessed by a general purpose or special purpose computer. By way of example, and not limitation, such computer-readable media can comprise RAM, ROM, EEPROM, CD-ROM or other optical disk storage, magnetic disk storage or other magnetic storage devices, or any other medium which can be used to carry or store desired program code means in the form of computer-executable instructions or data structures and which can be accessed by a general purpose or special purpose computer. When information is transferred or provided over a network or another communications connection (either hardwired, wireless, or a combination of hardwired or wireless) to a computer, the computer properly views the connection as a computer-readable medium. Thus, any such connection is properly termed a computer-readable medium. Combinations of the above should also be included within the scope of computer-readable media.
  • Computer-executable instructions comprise, for example, instructions and data which cause a general purpose computer, special purpose computer, or special purpose processing device to perform a certain function or group of functions. Although the subject matter has been described in language specific to structural features and/or methodological acts, it is to be understood that the subject matter defined in the appended claims is not necessarily limited to the specific features or acts described above. Rather, the specific features and acts described above are disclosed as example forms of implementing the claims.
  • As used herein, the term “module” or “component” can refer to software objects or routines that execute on the computing system. The different components, modules, engines, and services described herein may be implemented as objects or processes that execute on the computing system (e.g., as separate threads). While the system and methods described herein are preferably implemented in software, implementations in hardware or a combination of software and hardware are also possible and contemplated. In this description, a “computing entity” may be any computing system as previously defined herein, or any module or combination of modulates running on a computing system.
  • With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations may be expressly set forth herein for sake of clarity.
  • It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.”
  • In addition, where features or aspects of the disclosure are described in terms of Markush groups, those skilled in the art will recognize that the disclosure is also thereby described in terms of any individual member or subgroup of members of the Markush group.
  • As will be understood by one skilled in the art, for any and all purposes, such as in terms of providing a written description, all ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, etc. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, etc. As will also be understood by one skilled in the art all language such as “up to,” “at least,” and the like include the number recited and refer to ranges which can be subsequently broken down into subranges as discussed above. Finally, as will be understood by one skilled in the art, a range includes each individual member. Thus, for example, a group having 1-3 cells refers to groups having 1, 2, or 3 cells. Similarly, a group having 1-5 cells refers to groups having 1, 2, 3, 4, or 5 cells, and so forth.
  • From the foregoing, it will be appreciated that various embodiments of the present disclosure have been described herein for purposes of illustration, and that various modifications may be made without departing from the scope and spirit of the present disclosure. Accordingly, the various embodiments disclosed herein are not intended to be limiting, with the true scope and spirit being indicated by the following claims.
  • All references recited herein are incorporated herein by specific reference in their entirety.

Claims (21)

What is claimed is:
1. A muscle assessment method comprising:
determining a chronic muscle overuse index (CMOI), comprising:
selecting a CMOI protocol including an initial calibration activity;
creating a subject data set, including:
monitoring and/or recording relevant demographic data of the subject engaged in the muscle activity;
gathering surface electromyometry (sEMG) data from one or more sEMG sensors attached to the subject during the initial calibration activity;
plotting sEMG amplitude data points gathered over a period of time to establish the subject's data set;
referencing a database of secondary stored demographic and sEMG data sets to determine a related average dataset, the related average dataset being a subset of the secondary stored data sets based on a comparison of the subject's data set to the database of secondary stored demographic and sEMG data sets;
determining the CMOI based on a relationship between the subject's data set and the related average dataset.
2. The method of claim 1, further comprising projecting an estimated point of chronic muscle overuse beyond the initial calibration activity using the CMOI.
3. The method of claim 2, wherein the projected estimated point of chronic muscle overuse considers a projected sEMG data amplitude attribute of the subject beyond the initial calibration activity.
4. The method of claim 3, wherein the projected sEMG data amplitude attribute of the subject includes a projected high amplitude sEMG data point, projected low amplitude sEMG data point, and/or a projected difference of sEMG amplitude between a high amplitude data point and a low amplitude data point of the subject beyond the initial calibration activity.
5. The method of claim 3, wherein the projected sEMG data amplitude attribute of the subject includes a mean power frequency of projected sEMG data of the subject beyond the initial calibration activity.
6. The method of claim 1, further comprising estimating a time to exhaustion of the subject based on the CMOI following the initial calibration activity.
7. The method of claim 1, wherein the determined CMOI considers a comparison of high amplitude sEMG data and low amplitude sEMG data in the subject data set to high amplitude sEMG data and low amplitude sEMG data in the related average data set.
8. The method of claim 1, wherein the determined CMOI considers a comparison of a difference between high amplitude sEMG data and low amplitude sEMG data in the subject data set to a difference in high amplitude sEMG data and low amplitude sEMG data in the related average data set.
9. The method of claim 1, wherein the related average data set is identified by a comparison of high amplitude sEMG data and low amplitude sEMG data in the subject data set to high amplitude sEMG data and low amplitude sEMG data in the secondary data sets.
10. The method of claim 1, wherein the related average data set includes a subset of at least 35 data sets of the secondary data sets.
11. The method of claim 1, wherein the relevant demographic data of the subject engaged in the muscle activity includes an age, height, and/or weight of the subject.
12. The method of claim 11, wherein the relevant demographic data of the subject engaged in the muscle activity further includes a fitness attribute of the subject.
13. The method of claim 1, wherein the subject data set further includes one or more activity attributes, wherein the one or more activity attributes includes an activity type, an activity level, or rate of exhaustion associated with the activity.
14. The method of claim 1, further comprising continuing to monitor the subject's continued activity after the initial calibration activity by gathering sEMG data from the one or more sEMG sensors attached to the subject during the continued activity.
15. The method of claim 14, further comprising monitoring an observed rate of change (ROC) of amplitude in the sEMG data during the continued activity.
16. The method of claim 15, further comprising calculating a conversion factor based on the ROC and applying this conversion factor to identify a new estimated point of chronic muscle overuse.
17. The method of claim 16, wherein the new projected estimated chronic muscle overuse considers a new projected sEMG data amplitude attribute of the subject at the new projected estimated point of chronic muscle overuse.
18. The method of claim 15, wherein the new projected sEMG data amplitude attribute of the subject includes a new projected high amplitude sEMG data, new projected low amplitude sEMG data, and/or new a projected difference of sEMG amplitude between a high amplitude data and a low amplitude data.
19. The method of claim 15, wherein the new projected sEMG data amplitude attribute of the subject includes a new mean power frequency of projected sEMG data.
20. The method of claim 15, further comprising estimating a new time to exhaustion of the subject based on the conversion factor.
21. A muscle assessment method comprising:
determining a chronic muscle overuse index (CMOI), comprising:
selecting a CMOI protocol including an initial calibration activity;
creating a subject data set, including:
monitoring and/or recording relevant demographic data of the subject engaged in the muscle activity;
gathering surface electromyometry (sEMG) data from one or more sEMG sensors attached to the subject during the initial calibration activity;
plotting sEMG amplitude data points gathered over a period of time to establish the subject's data set;
referencing a database of secondary stored demographic and sEMG data sets to determine a related average dataset, the related average dataset being a subset of the secondary stored data sets based on a comparison of the subject's data set to the database of secondary stored demographic and sEMG data sets;
determining the CMOI based on a relationship between the subject's data set and the related average dataset; and
estimating a time to exhaustion of the subject based on the CMOI following the initial calibration activity;
dividing the estimated time to exhaustion of the subject into two or more zones; and
alerting the subject as to the one or more zones based on an elapsed time and/or additional sEMG amplitude continued activity data gathered subsequent to the initial calibration activity;
monitoring an observed rate of change (ROC) of amplitude in the sEMG data during the continued activity; and
modifying the two or more zones of the estimated time to exhaustion of the subject based on the observed ROC.
US14/847,714 2010-09-21 2015-09-08 Metrics & algorithms for interpretation of muscular use including chronic muscle overuse index Abandoned US20150374302A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/847,714 US20150374302A1 (en) 2010-09-21 2015-09-08 Metrics & algorithms for interpretation of muscular use including chronic muscle overuse index

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US38505110P 2010-09-21 2010-09-21
US38504610P 2010-09-21 2010-09-21
US38503810P 2010-09-21 2010-09-21
US38505310P 2010-09-21 2010-09-21
US38504910P 2010-09-21 2010-09-21
US38504810P 2010-09-21 2010-09-21
US201161514148P 2011-08-02 2011-08-02
US13/239,064 US9131888B2 (en) 2010-09-21 2011-09-21 Metrics and algorithms for interpretation of muscular use
US14/847,714 US20150374302A1 (en) 2010-09-21 2015-09-08 Metrics & algorithms for interpretation of muscular use including chronic muscle overuse index

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/239,064 Division US9131888B2 (en) 2010-09-21 2011-09-21 Metrics and algorithms for interpretation of muscular use

Publications (1)

Publication Number Publication Date
US20150374302A1 true US20150374302A1 (en) 2015-12-31

Family

ID=45818348

Family Applications (9)

Application Number Title Priority Date Filing Date
US13/239,033 Expired - Fee Related US9295424B2 (en) 2010-09-21 2011-09-21 Systems for assessing and optimizing muscular performance
US13/239,105 Expired - Fee Related US9107627B2 (en) 2010-09-21 2011-09-21 Method for assessing and optimizing muscular performance including a muscleprint protocol
US13/239,064 Expired - Fee Related US9131888B2 (en) 2010-09-21 2011-09-21 Metrics and algorithms for interpretation of muscular use
US13/239,079 Abandoned US20120071770A1 (en) 2010-09-21 2011-09-21 Methods for promoting fitness in connection with electrophysiology data
US14/795,091 Active 2032-06-12 US10058265B2 (en) 2010-09-21 2015-07-09 Methods for assessing and optimizing muscular performance including a controlled activity training protocol
US14/795,005 Active 2032-07-22 US10010260B2 (en) 2010-09-21 2015-07-09 Methods for assessing and optimizing muscular performance including a stride rate tuning protocol
US14/795,100 Active 2032-07-25 US9918654B2 (en) 2010-09-21 2015-07-09 Methods for assessing and optimizing muscular performance including a frequency based, amplitude adjusted root mean square protocol
US14/847,714 Abandoned US20150374302A1 (en) 2010-09-21 2015-09-08 Metrics & algorithms for interpretation of muscular use including chronic muscle overuse index
US15/083,252 Active 2036-10-16 US11445919B2 (en) 2010-09-21 2016-03-28 Systems for assessing and optimizing muscular performance

Family Applications Before (7)

Application Number Title Priority Date Filing Date
US13/239,033 Expired - Fee Related US9295424B2 (en) 2010-09-21 2011-09-21 Systems for assessing and optimizing muscular performance
US13/239,105 Expired - Fee Related US9107627B2 (en) 2010-09-21 2011-09-21 Method for assessing and optimizing muscular performance including a muscleprint protocol
US13/239,064 Expired - Fee Related US9131888B2 (en) 2010-09-21 2011-09-21 Metrics and algorithms for interpretation of muscular use
US13/239,079 Abandoned US20120071770A1 (en) 2010-09-21 2011-09-21 Methods for promoting fitness in connection with electrophysiology data
US14/795,091 Active 2032-06-12 US10058265B2 (en) 2010-09-21 2015-07-09 Methods for assessing and optimizing muscular performance including a controlled activity training protocol
US14/795,005 Active 2032-07-22 US10010260B2 (en) 2010-09-21 2015-07-09 Methods for assessing and optimizing muscular performance including a stride rate tuning protocol
US14/795,100 Active 2032-07-25 US9918654B2 (en) 2010-09-21 2015-07-09 Methods for assessing and optimizing muscular performance including a frequency based, amplitude adjusted root mean square protocol

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/083,252 Active 2036-10-16 US11445919B2 (en) 2010-09-21 2016-03-28 Systems for assessing and optimizing muscular performance

Country Status (2)

Country Link
US (9) US9295424B2 (en)
WO (4) WO2012040401A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018110730A (en) * 2017-01-12 2018-07-19 ブリヂストンサイクル株式会社 Muscle activity state analysis system, muscle activity state analysis method and program
CN108309295A (en) * 2018-02-11 2018-07-24 宁波工程学院 A kind of arm muscular strength assessment method

Families Citing this family (179)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
AU2006239221C1 (en) 2005-04-28 2012-08-16 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
KR101611240B1 (en) 2006-10-25 2016-04-11 프로테우스 디지털 헬스, 인코포레이티드 Controlled activation ingestible identifier
EP3785599B1 (en) 2007-02-01 2022-08-03 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker systems
CA2676280C (en) 2007-02-14 2018-05-22 Proteus Biomedical, Inc. In-body power source having high surface area electrode
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US11126321B2 (en) 2007-09-04 2021-09-21 Apple Inc. Application menu user interface
WO2010005877A2 (en) 2008-07-08 2010-01-14 Proteus Biomedical, Inc. Ingestible event marker data framework
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
SG172846A1 (en) 2009-01-06 2011-08-29 Proteus Biomedical Inc Ingestion-related biofeedback and personalized medical therapy method and system
WO2010129288A2 (en) 2009-04-28 2010-11-11 Proteus Biomedical, Inc. Highly reliable ingestible event markers and methods for using the same
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
SG182825A1 (en) 2010-02-01 2012-09-27 Proteus Biomedical Inc Data gathering system
CA2795746C (en) 2010-04-07 2019-10-01 Timothy Robertson Miniature ingestible device
WO2011143490A2 (en) 2010-05-12 2011-11-17 Irhythm Technologies, Inc. Device features and design elements for long-term adhesion
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
WO2012040401A2 (en) * 2010-09-21 2012-03-29 Somaxis Incorporated Systems for assessing and optimizing muscular performance
EP2642983A4 (en) 2010-11-22 2014-03-12 Proteus Digital Health Inc Ingestible device with pharmaceutical product
US11064910B2 (en) 2010-12-08 2021-07-20 Activbody, Inc. Physical activity monitoring system
JP2014514032A (en) * 2011-03-11 2014-06-19 プロテウス デジタル ヘルス, インコーポレイテッド Wearable personal body-related devices with various physical configurations
US9069380B2 (en) 2011-06-10 2015-06-30 Aliphcom Media device, application, and content management using sensory input
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
IN2014MN00183A (en) 2011-07-21 2015-06-19 Proteus Digital Health Inc
USD733760S1 (en) 2011-10-11 2015-07-07 Proteus Digital Health, Inc. Display screen portion having a graphical user interface for patient monitoring
USD733727S1 (en) * 2011-10-11 2015-07-07 Proteus Digital Health, Inc. Display screen portion having a graphical user interface for patient monitoring
USD733761S1 (en) 2011-10-11 2015-07-07 Proteus Digital Health, Inc. Display screen portion having a graphical user interface for patient monitoring
US9734304B2 (en) 2011-12-02 2017-08-15 Lumiradx Uk Ltd Versatile sensors with data fusion functionality
US9700222B2 (en) 2011-12-02 2017-07-11 Lumiradx Uk Ltd Health-monitor patch
US20130244211A1 (en) * 2012-03-15 2013-09-19 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for measuring, analyzing, and providing feedback for movement in multidimensional space
JP5665241B2 (en) * 2012-03-21 2015-02-04 パナソニックIpマネジメント株式会社 Eye fatigue determination device and operation method thereof
US9459781B2 (en) 2012-05-09 2016-10-04 Apple Inc. Context-specific user interfaces for displaying animated sequences
US10102345B2 (en) 2012-06-19 2018-10-16 Activbody, Inc. Personal wellness management platform
US10133849B2 (en) 2012-06-19 2018-11-20 Activbody, Inc. Merchandizing, socializing, and/or gaming via a personal wellness device and/or a personal wellness platform
US9230064B2 (en) 2012-06-19 2016-01-05 EZ as a Drink Productions, Inc. Personal wellness device
US9301032B1 (en) 2012-07-26 2016-03-29 Heartbuds, Llc Stethoscope chestpiece usable with a portable electronic device and related methods
USD732049S1 (en) * 2012-11-08 2015-06-16 Uber Technologies, Inc. Computing device display screen with electronic summary or receipt graphical user interface
USD714334S1 (en) 2012-12-20 2014-09-30 Proteus Digital Health, Inc. Display screen portion having a graphical user interface for patient monitoring
USD713854S1 (en) 2012-12-20 2014-09-23 Proteus Digital Health, Inc. Display screen portion having a graphical user interface for patient monitoring
USD714335S1 (en) 2012-12-20 2014-09-30 Proteus Digital Health, Inc. Display screen portion having a graphical user interface for patient monitoring
USD714336S1 (en) 2012-12-20 2014-09-30 Proteus Digital Health, Inc. Display screen portion having a graphical user interface for patient monitoring
CN103020480A (en) * 2012-12-28 2013-04-03 安科智慧城市技术(中国)有限公司 Method, terminal and system for collecting health information of aged people
US10244986B2 (en) * 2013-01-23 2019-04-02 Avery Dennison Corporation Wireless sensor patches and methods of manufacturing
WO2014116825A1 (en) * 2013-01-24 2014-07-31 Irhythm Technologies, Inc. Physiological monitoring device
JP2016508529A (en) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス, インコーポレイテッド Highly expandable polymer film and composition containing the same
CN105210067B (en) * 2013-03-04 2021-04-30 博能电子公司 Computing a physiological state of a user related to physical exercise
US10772522B2 (en) * 2013-03-12 2020-09-15 Vital Connect, Inc. Disposable biometric patch device
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
WO2014143776A2 (en) 2013-03-15 2014-09-18 Bodhi Technology Ventures Llc Providing remote interactions with host device using a wireless device
JP5941240B2 (en) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス, インコーポレイテッド Metal detector device, system and method
JP6498177B2 (en) 2013-03-15 2019-04-10 プロテウス デジタル ヘルス, インコーポレイテッド Identity authentication system and method
US9229476B2 (en) 2013-05-08 2016-01-05 EZ as a Drink Productions, Inc. Personal handheld electronic device with a touchscreen on a peripheral surface
US20140364702A1 (en) * 2013-06-06 2014-12-11 Valeriy Nasedkin Apparatus and method for functional state and/or performance assessment and training program adjustment
CN103315737B (en) * 2013-06-18 2015-04-15 上海交通大学 Wearable multi-channel surface electromyogram signal collecting armlet
US9262064B2 (en) 2013-07-09 2016-02-16 EZ as a Drink Productions, Inc. Handheld computing platform with integrated pressure sensor and associated methods of use
US11921471B2 (en) 2013-08-16 2024-03-05 Meta Platforms Technologies, Llc Systems, articles, and methods for wearable devices having secondary power sources in links of a band for providing secondary power in addition to a primary power source
US10188309B2 (en) 2013-11-27 2019-01-29 North Inc. Systems, articles, and methods for electromyography sensors
US20150124566A1 (en) 2013-10-04 2015-05-07 Thalmic Labs Inc. Systems, articles and methods for wearable electronic devices employing contact sensors
CN103445763B (en) * 2013-08-26 2015-08-26 华中科技大学 A kind of health monitoring systems based on epidermis electronics
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9737758B1 (en) * 2013-09-20 2017-08-22 Sparta Software Corporation Method and system for generating athletic signatures
RU2736776C2 (en) 2013-09-20 2020-11-20 Протеус Диджитал Хелс, Инк. Methods, devices and systems for receiving and decoding signals in the presence of noise using sections and deformation
US9682280B1 (en) * 2013-09-20 2017-06-20 Sparta Software Corporation System for analysing athletic movement
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10471290B1 (en) * 2013-10-10 2019-11-12 Sparta Software Corporation Method and system for training athletes based on athletic signatures and prescription
EP3074900B1 (en) * 2013-10-30 2018-06-27 Mehmet, Tansu Method for preparing a customized exercise strategy
US20150126893A1 (en) * 2013-11-01 2015-05-07 Maryrose Cusimano Reaston Method For Determining If Surgically-Implanted Hardware Should Be Removed
US10084880B2 (en) * 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10270898B2 (en) 2014-05-30 2019-04-23 Apple Inc. Wellness aggregator
EP3366216A1 (en) * 2014-02-19 2018-08-29 Lumiradx Uk Ltd Health monitor
JP6582285B2 (en) * 2014-02-24 2019-10-02 ソニー株式会社 Proximity-based data exchange and user authentication between smart wearable devices
US9770179B2 (en) 2014-03-26 2017-09-26 GestureLogic Inc. System, method and device for detecting heart rate
US10327670B2 (en) 2014-03-26 2019-06-25 GestureLogic Inc. Systems, methods and devices for exercise and activity metric computation
US9782104B2 (en) * 2014-03-26 2017-10-10 GestureLogic Inc. Systems, methods and devices for acquiring and processing physiological signals
JP6707444B2 (en) * 2014-03-27 2020-06-10 株式会社根本杏林堂 Sensor Pad Kits for Leak Detection Sensors, Leak Detection Systems, and Medication Injection Systems
US10124246B2 (en) 2014-04-21 2018-11-13 Activbody, Inc. Pressure sensitive peripheral devices, and associated methods of use
CN116301544A (en) 2014-06-27 2023-06-23 苹果公司 Reduced size user interface
US10135905B2 (en) 2014-07-21 2018-11-20 Apple Inc. Remote user interface
HK1203120A2 (en) * 2014-08-26 2015-10-16 高平 A gait monitor and a method of monitoring the gait of a person
US10456604B2 (en) 2014-08-26 2019-10-29 Elwha Llc Garment system including at least one therapeutic stimulation delivery device and related methods
US11638676B2 (en) 2014-08-26 2023-05-02 Ventrk, Llc Garment system including at least one sensor and at least one actuator responsive to the sensor and related methods
US10232165B2 (en) 2015-01-29 2019-03-19 Elwha Llc Garment system including at least one sensor and at least one actuator responsive to the sensor and related methods
US10668305B2 (en) 2014-08-26 2020-06-02 Elwha Llc Garment system including at least one therapeutic stimulation delivery device and related methods
US9687404B2 (en) 2014-08-26 2017-06-27 Elwha Llc Garment system including at least one muscle or joint activity sensor and at least one actuator responsive to the sensor and related methods
KR101776098B1 (en) 2014-09-02 2017-09-07 애플 인크. Physical activity and workout monitor
EP3189406B1 (en) 2014-09-02 2022-09-07 Apple Inc. Phone user interface
WO2016036552A1 (en) 2014-09-02 2016-03-10 Apple Inc. User interactions for a mapping application
US11064936B2 (en) * 2014-09-04 2021-07-20 Active4D, Inc. Shoulder monitoring and treatment system
US10223931B1 (en) * 2014-09-05 2019-03-05 Fusionetics, LLC Systems and methods for compensation analysis and targeted, corrective program generation
JP6480147B2 (en) 2014-10-21 2019-03-06 株式会社タニタ Muscle state change determination device, muscle state change determination method, and program
WO2016070128A1 (en) 2014-10-31 2016-05-06 Irhythm Technologies, Inc. Wireless physiological monitoring device and systems
US9888869B2 (en) * 2014-12-09 2018-02-13 The Johns Hopkins University Neural block determination
US10032227B2 (en) * 2014-12-30 2018-07-24 Johnson Health Tech Co., Ltd. Exercise apparatus with exercise use verification function and verifying method
US20210209695A1 (en) * 2014-12-30 2021-07-08 Johnson Health Tech Co., Ltd. Exercise apparatus with exercise use verification function and verifying method
WO2016112021A1 (en) * 2015-01-05 2016-07-14 Nike, Inc. Energy expenditure calculation using data from multiple devices
EP3998762A1 (en) 2015-02-02 2022-05-18 Apple Inc. Device, method, and graphical user interface for establishing a relationship and connection between two devices
US9700263B2 (en) * 2015-05-27 2017-07-11 Tarak Dolat Patel Electronic physical therapy and rehabilitation rolling device with tactile sensor array
US10275116B2 (en) 2015-06-07 2019-04-30 Apple Inc. Browser with docked tabs
CA2934003A1 (en) * 2015-06-23 2016-12-23 Reperformance Inc. System and method for normalizing activity results
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
KR101788664B1 (en) * 2015-08-07 2017-10-20 전자부품연구원 Method of monitoring user's movement, monitoring system performing the same
CN113521710A (en) 2015-08-20 2021-10-22 苹果公司 Motion-based dial and complex function block
US20170173391A1 (en) 2015-12-18 2017-06-22 MAD Apparel, Inc. Adaptive calibration for sensor-equipped athletic garments
US10357688B2 (en) 2016-11-18 2019-07-23 MAD Apparel, Inc. Exercise biofeedback using sensor-equipped athletic garments
CN107212855A (en) * 2016-03-22 2017-09-29 广州柏颐信息科技有限公司 Intelligence nurse bracelet and intelligent safeguard system
CN105975106B (en) * 2016-04-28 2019-01-15 大连海事大学 A kind of intelligent health-care mouse and its carry out hand therapeutic massage method
CN105771182B (en) * 2016-05-13 2018-06-29 中国科学院自动化研究所 A kind of healing robot active training control method and device
DE102016006099B4 (en) * 2016-05-20 2018-10-11 IVS Engineering GbR (vertretungsbererchtigter Gesellschafter Herr Thomas Steiger, 57537 Wissen) Training monitoring procedure
US20190313934A1 (en) * 2016-06-10 2019-10-17 Biotrak Health, Inc. Device and system for monitoring and treating muscle tension-related medical conditions
DK201770423A1 (en) 2016-06-11 2018-01-15 Apple Inc Activity and workout updates
US10873786B2 (en) 2016-06-12 2020-12-22 Apple Inc. Recording and broadcasting application visual output
US11216119B2 (en) 2016-06-12 2022-01-04 Apple Inc. Displaying a predetermined view of an application
US11471085B2 (en) * 2016-07-11 2022-10-18 Strive Tech Inc. Algorithms for detecting athletic fatigue, and associated methods
EP3487393A4 (en) 2016-07-22 2020-01-15 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
WO2018020513A1 (en) * 2016-07-29 2018-02-01 Vaish Diwakar A system for recognizing muscle activities and method thereof.
US10736543B2 (en) 2016-09-22 2020-08-11 Apple Inc. Workout monitor interface
CN109963499B (en) 2016-10-26 2022-02-25 大冢制药株式会社 Method for manufacturing capsules with ingestible event markers
US11545265B2 (en) * 2016-11-04 2023-01-03 The Regents Of The University Of California Predictive respiratory monitor and system
US11179601B2 (en) 2016-11-18 2021-11-23 MAD Apparel, Inc. Training program customization using sensor-equipped athletic garments
US11185270B1 (en) * 2017-02-03 2021-11-30 Yongwu Yang Wearable device and method for monitoring muscle tension and other physiological data
WO2018191366A1 (en) * 2017-04-11 2018-10-18 Sabic Global Technologies B.V. Wireless cardiac monitoring system utilizing adhesive microstructures
US10845955B2 (en) 2017-05-15 2020-11-24 Apple Inc. Displaying a scrollable list of affordances associated with physical activities
JP2020528770A (en) * 2017-06-05 2020-10-01 パウエル マンスフィールド, インコーポレイテッド Penetration sensor for assessing neuromuscular function
US20190000384A1 (en) * 2017-06-30 2019-01-03 Myant Inc. Method for sensing of biometric data and use thereof for determining emotional state of a user
EP3446624A1 (en) 2017-08-23 2019-02-27 Koninklijke Philips N.V. Skin electrode
US10896760B2 (en) 2017-10-05 2021-01-19 International Business Machines Corporation Estimation of muscle activities using the muscles relationship during simulating movements
WO2019079757A1 (en) 2017-10-19 2019-04-25 Ctrl-Labs Corporation Systems and methods for identifying biological structures associated with neuromuscular source signals
EP3476288A1 (en) 2017-10-31 2019-05-01 Nokia Technologies Oy A method, apparatus and computer program for synchronizing biopotential signals
US11907423B2 (en) 2019-11-25 2024-02-20 Meta Platforms Technologies, Llc Systems and methods for contextualized interactions with an environment
US11493993B2 (en) 2019-09-04 2022-11-08 Meta Platforms Technologies, Llc Systems, methods, and interfaces for performing inputs based on neuromuscular control
US11150730B1 (en) 2019-04-30 2021-10-19 Facebook Technologies, Llc Devices, systems, and methods for controlling computing devices via neuromuscular signals of users
US11481030B2 (en) 2019-03-29 2022-10-25 Meta Platforms Technologies, Llc Methods and apparatus for gesture detection and classification
WO2019149331A1 (en) 2018-02-05 2019-08-08 Precure Aps A system for monitoring physical movements of a user
CN108309294A (en) * 2018-02-07 2018-07-24 上海健康医学院 A kind of human body active state movable recognition system
CN110151150B (en) 2018-02-12 2022-03-29 财团法人工业技术研究院 Physiological sensor device and system, correction method and wearable device
DK180246B1 (en) 2018-03-12 2020-09-11 Apple Inc User interfaces for health monitoring
US11317833B2 (en) 2018-05-07 2022-05-03 Apple Inc. Displaying user interfaces associated with physical activities
DK179992B1 (en) 2018-05-07 2020-01-14 Apple Inc. Visning af brugergrænseflader associeret med fysiske aktiviteter
DK180171B1 (en) 2018-05-07 2020-07-14 Apple Inc USER INTERFACES FOR SHARING CONTEXTUALLY RELEVANT MEDIA CONTENT
US11246531B2 (en) 2018-05-10 2022-02-15 MAD Apparel, Inc. Fatigue measurement in a sensor equipped garment
CN112153936A (en) * 2018-05-22 2020-12-29 利菲伦斯科技有限责任公司 Monitoring physiological parameters and temporal feedback during an activity to enhance a subject's performance
US10779748B2 (en) 2018-07-15 2020-09-22 Ifgcure Holdings, Llc Biometric electromyography sensor device for fatigue monitoring and injury prevention and methods for using same
CN109846480B (en) * 2018-08-09 2021-10-29 江汉大学 Method, device and storage medium for detecting comprehensive muscle fatigue
CN109157214A (en) * 2018-09-11 2019-01-08 河南工业大学 A method of the online removal eye electricity artefact suitable for single channel EEG signals
EP3853698A4 (en) 2018-09-20 2021-11-17 Facebook Technologies, LLC Neuromuscular text entry, writing and drawing in augmented reality systems
US10953307B2 (en) 2018-09-28 2021-03-23 Apple Inc. Swim tracking and notifications for wearable devices
JP2022507628A (en) * 2018-11-16 2022-01-18 フェイスブック・テクノロジーズ・リミテッド・ライアビリティ・カンパニー Feedback from neuromuscular activation in various types of virtual reality and / or augmented reality environments
EP3886693A4 (en) 2018-11-27 2022-06-08 Facebook Technologies, LLC. Methods and apparatus for autocalibration of a wearable electrode sensor system
CN109846487B (en) * 2019-02-26 2021-12-31 浙江理工大学 Thigh movement posture measuring method and device based on MIMU/sEMG fusion
CN110074760B (en) * 2019-04-28 2021-11-23 太平洋未来科技(深圳)有限公司 Instrument capable of reading sensor value for measuring human muscle movement strength
US11863700B2 (en) 2019-05-06 2024-01-02 Apple Inc. Providing user interfaces based on use contexts and managing playback of media
DK201970532A1 (en) 2019-05-06 2021-05-03 Apple Inc Activity trends and workouts
US11228835B2 (en) 2019-06-01 2022-01-18 Apple Inc. User interfaces for managing audio exposure
US11234077B2 (en) 2019-06-01 2022-01-25 Apple Inc. User interfaces for managing audio exposure
US11209957B2 (en) 2019-06-01 2021-12-28 Apple Inc. User interfaces for cycle tracking
US11152100B2 (en) 2019-06-01 2021-10-19 Apple Inc. Health application user interfaces
WO2020247261A1 (en) 2019-06-01 2020-12-10 Apple Inc. Multi-modal activity tracking user interface
EP4009863A1 (en) 2019-08-06 2022-06-15 PreCure ApS A system for monitoring, evaluating and providing feedback of physical movements of a user
WO2021051121A1 (en) 2019-09-09 2021-03-18 Apple Inc. Research study user interfaces
CN110638449B (en) * 2019-09-30 2021-05-18 福州大学 Muscle quantitative analysis method based on mechanical work
CN110720912B (en) * 2019-10-12 2022-04-26 宁波工程学院 Muscle movement unit extraction method based on waveform correlation
CN110720910B (en) * 2019-10-12 2022-03-29 宁波工程学院 Muscle movement unit searching method based on correlation
CA3171482A1 (en) 2020-02-12 2021-08-19 Irhythm Technologies, Inc Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient
DK181076B1 (en) 2020-02-14 2022-11-25 Apple Inc USER INTERFACES FOR TRAINING CONTENT
US20210275077A1 (en) * 2020-03-05 2021-09-09 Wolfgang Richter Device for measuring or stimulating vital signs of a user
CN111481196B (en) * 2020-04-16 2023-06-27 京东科技信息技术有限公司 Exoskeleton power-assisted efficiency detection method and device, electronic equipment and storage medium
DK181037B1 (en) 2020-06-02 2022-10-10 Apple Inc User interfaces for health applications
WO2022032118A1 (en) 2020-08-06 2022-02-10 Irhythm Technologies, Inc. Electrical components for physiological monitoring device
CN116322497A (en) 2020-08-06 2023-06-23 意锐瑟科技公司 Viscous physiological monitoring device
US11698710B2 (en) 2020-08-31 2023-07-11 Apple Inc. User interfaces for logging user activities
CN112932468A (en) * 2021-01-26 2021-06-11 京东方科技集团股份有限公司 Monitoring system and monitoring method for muscle movement ability
US20230260619A1 (en) * 2021-02-19 2023-08-17 Strive Tech Inc. Algorithmic service and training recommendations based on data, and associated systems and methods
US11868531B1 (en) 2021-04-08 2024-01-09 Meta Platforms Technologies, Llc Wearable device providing for thumb-to-finger-based input gestures detected based on neuromuscular signals, and systems and methods of use thereof
US11915805B2 (en) 2021-06-06 2024-02-27 Apple Inc. User interfaces for shared health-related data
EP4138089A1 (en) 2021-08-20 2023-02-22 Deweer, N. Method, system and computer program for personalized training
CN114431832B (en) * 2021-12-27 2023-10-20 同济大学 Quantitative analysis method for muscle energy consumption
US11896871B2 (en) 2022-06-05 2024-02-13 Apple Inc. User interfaces for physical activity information

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505208A (en) * 1993-12-10 1996-04-09 Toomin Research Group Method for determining muscle dysfunction
US20110118621A1 (en) * 2009-11-13 2011-05-19 Chu Tun-Hsiao Muscular energy state analysis system and method for swing motion and computer program product thereof

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5243998A (en) * 1989-05-25 1993-09-14 The Rockefeller University Automatic operant conditioning system
US5263481A (en) * 1992-05-21 1993-11-23 Jens Axelgaard Electrode system with disposable gel
US5349963A (en) * 1993-08-06 1994-09-27 Sanhill Oy Method and apparatus for measuring muscle fatigue
US5377258A (en) * 1993-08-30 1994-12-27 National Medical Research Council Method and apparatus for an automated and interactive behavioral guidance system
DE4329898A1 (en) * 1993-09-04 1995-04-06 Marcus Dr Besson Wireless medical diagnostic and monitoring device
US5462065A (en) * 1994-08-17 1995-10-31 Cusimano; Maryrose Integrated movement analyziing system
US6327487B1 (en) * 1995-05-04 2001-12-04 Robert A. Stratbucker Bioelectric interface
US6265978B1 (en) * 1996-07-14 2001-07-24 Atlas Researches, Ltd. Method and apparatus for monitoring states of consciousness, drowsiness, distress, and performance
US20020180605A1 (en) * 1997-11-11 2002-12-05 Ozguz Volkan H. Wearable biomonitor with flexible thinned integrated circuit
US6434410B1 (en) * 1998-06-19 2002-08-13 Aspect Medical Systems, Inc. Electrode for measuring electrophysiological signals using liquid electrolytic gel with a high salt concentration
BR9913610A (en) * 1998-09-04 2001-10-09 Wolfe Res Pty Ltd Medical implant system
US6496724B1 (en) * 1998-12-31 2002-12-17 Advanced Brain Monitoring, Inc. Method for the quantification of human alertness
DE19929328A1 (en) * 1999-06-26 2001-01-04 Daimlerchrysler Aerospace Ag Device for long-term medical monitoring of people
CA2386673A1 (en) * 1999-10-07 2001-04-12 Anthony R. Montgomery Physiological signal monitoring apparatus and method
US6585622B1 (en) * 1999-12-03 2003-07-01 Nike, Inc. Interactive use an athletic performance monitoring and reward method, system, and computer program product
US6440067B1 (en) 2000-02-28 2002-08-27 Altec, Inc. System and method for remotely monitoring functional activities
US6352516B1 (en) * 2000-03-27 2002-03-05 San Diego State University Foundation Fatigue monitoring device and method
KR20000072178A (en) 2000-08-11 2000-12-05 조상현 Method and system for monitoring muscle fatigue using of EMG median frequency
FI119716B (en) * 2000-10-18 2009-02-27 Polar Electro Oy Electrode structure and heart rate measurement arrangement
US7171331B2 (en) * 2001-12-17 2007-01-30 Phatrat Technology, Llc Shoes employing monitoring devices, and associated methods
JP3610455B2 (en) * 2001-01-30 2005-01-12 独立行政法人産業技術総合研究所 EMG pattern identification device
US7197357B2 (en) * 2001-07-17 2007-03-27 Life Sync Corporation Wireless ECG system
US6965794B2 (en) * 2001-10-05 2005-11-15 Fasstech, Inc. Apparatus for routing electromyography signals
US6643541B2 (en) * 2001-12-07 2003-11-04 Motorola, Inc Wireless electromyography sensor and system
US20030149349A1 (en) * 2001-12-18 2003-08-07 Jensen Thomas P. Integral patch type electronic physiological sensor
US6708050B2 (en) * 2002-03-28 2004-03-16 3M Innovative Properties Company Wireless electrode having activatable power cell
JP2004049789A (en) * 2002-07-24 2004-02-19 Tanita Corp Muscular fatigue measuring system
US20040260281A1 (en) * 2002-09-19 2004-12-23 Baxter Chester O. Finger tip electrosurgical medical device
MXPA05003688A (en) * 2002-10-09 2005-09-30 Bodymedia Inc Method and apparatus for auto journaling of continuous or discrete body states utilizing physiological and/or contextual parameters.
GB2394294A (en) * 2002-10-18 2004-04-21 Cambridge Neurotechnology Ltd Cardiac sensor with accelerometer
US20040097838A1 (en) * 2002-11-19 2004-05-20 Paske William C. System and apparatus for providing quantified hand analysis
US20040103146A1 (en) * 2002-11-26 2004-05-27 Seung-Hun Park Method and system for physically exercising with plurality of participants using network
JP2006520657A (en) * 2003-03-21 2006-09-14 ウェルチ・アリン・インコーポレーテッド Personal condition physiological monitoring system and structure, and monitoring method
SE0303062L (en) * 2003-11-19 2005-05-20 Maquet Critical Care Ab Method and device for filtering out an EMG signal
US7699753B2 (en) * 2004-01-30 2010-04-20 Carl Daikeler Method and apparatus for creating a virtual workout community
ATE473678T1 (en) * 2004-02-27 2010-07-15 Koninkl Philips Electronics Nv PORTABLE WIRELESS DEVICE FOR MONITORING, ANALYZING AND COMMUNICATING PHYSIOLOGICAL STATUS
KR100624424B1 (en) * 2004-06-10 2006-09-19 삼성전자주식회사 Electric stimulus generating device and method, and Health training/monitoring apparatus and method using it
WO2006009767A1 (en) * 2004-06-18 2006-01-26 Neuronetrix, Inc Wireless electrode for biopotential measurement
JP4549758B2 (en) * 2004-06-30 2010-09-22 本田技研工業株式会社 Exercise measurement method, exercise measurement device, and exercise measurement program
FI120960B (en) * 2004-07-01 2010-05-31 Suunto Oy Method and apparatus for measuring the level of performance and fatigue during an exercise performance
US8109858B2 (en) * 2004-07-28 2012-02-07 William G Redmann Device and method for exercise prescription, detection of successful performance, and provision of reward therefore
US20060135858A1 (en) * 2004-09-13 2006-06-22 International Business Machines Corporation Displaying information related to a physical parameter of an individual
US7846067B2 (en) * 2004-10-22 2010-12-07 Mytrak Health System Inc. Fatigue and consistency in exercising
IL165232A0 (en) * 2004-11-16 2005-12-18 Tapuz Medical Technologies T M An ergometry belt
JP4731936B2 (en) * 2005-02-09 2011-07-27 本田技研工業株式会社 Rotary variable resistor
EP1871218B1 (en) * 2005-03-09 2012-05-16 Coloplast A/S A three-dimensional adhesive device having a microelectronic system embedded therein
US8187209B1 (en) * 2005-03-17 2012-05-29 Great Lakes Neurotechnologies Inc Movement disorder monitoring system and method
JP5571307B2 (en) * 2005-05-06 2014-08-13 コーニンクレッカ フィリップス エヌ ヴェ Patient monitoring system, cognitive device and method for transporting physiological information to a remote location
US7641592B2 (en) * 2005-05-06 2010-01-05 Jonathan Roche Ventures, Llc Interval fitness training
US7481779B2 (en) * 2005-07-21 2009-01-27 William Thomas Large Method of managing and preventing the onset of computer and sedentary work related fatigue
FI20055544L (en) * 2005-10-07 2007-04-08 Polar Electro Oy Procedures, performance meters and computer programs for determining performance
US7733224B2 (en) * 2006-06-30 2010-06-08 Bao Tran Mesh network personal emergency response appliance
US8016776B2 (en) * 2005-12-02 2011-09-13 Medtronic, Inc. Wearable ambulatory data recorder
US7365647B2 (en) * 2005-12-23 2008-04-29 Avinoam Nativ Kinesthetic training system with composite feedback
US8150502B2 (en) * 2006-02-06 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive cardiac monitor and methods of using continuously recorded cardiac data
US7593769B1 (en) 2006-02-14 2009-09-22 Iq Biolabs, Inc. Surface electromyography index
US20070232869A1 (en) * 2006-03-31 2007-10-04 Casio Computer Co., Ltd. Biological information measuring device and biological information measuring system
US20070249957A1 (en) * 2006-04-19 2007-10-25 Patrick Gentempo Mapping spinal muscle tone
US7539533B2 (en) 2006-05-16 2009-05-26 Bao Tran Mesh network monitoring appliance
JP2007312921A (en) * 2006-05-24 2007-12-06 Casio Comput Co Ltd Biological information measuring apparatus and biological information measuring system
US7454313B2 (en) * 2006-05-30 2008-11-18 Honeywell International Inc. Hierarchical workload monitoring for optimal subordinate tasking
EP2032029A4 (en) * 2006-06-14 2012-07-04 Jolife Ab Ecg electrode and electrode support
GB0612997D0 (en) * 2006-06-30 2006-08-09 Woods Fergal Exercise monitoring device and motivation lottery system employing same
US20080033252A1 (en) * 2006-08-02 2008-02-07 Hector Jose Estrella Detection, measurement, and communication of physiological properties, and generation and communication of activation signals in response to physiological properties
US8437844B2 (en) * 2006-08-21 2013-05-07 Holland Bloorview Kids Rehabilitation Hospital Method, system and apparatus for real-time classification of muscle signals from self-selected intentional movements
US7771320B2 (en) * 2006-09-07 2010-08-10 Nike, Inc. Athletic performance sensing and/or tracking systems and methods
US8235724B2 (en) * 2006-09-21 2012-08-07 Apple Inc. Dynamically adaptive scheduling system
US8001472B2 (en) * 2006-09-21 2011-08-16 Apple Inc. Systems and methods for providing audio and visual cues via a portable electronic device
US7828753B2 (en) * 2006-10-18 2010-11-09 Convergent Engineering, Inc. Electrode interface system
WO2008073491A1 (en) * 2006-12-11 2008-06-19 University Of Florida Research Foundation, Inc. System and method for analyzing progress of labor and preterm labor
CN101541387B (en) * 2007-02-14 2013-04-17 耐克国际有限公司 Collection and display of athletic information
US8627355B2 (en) * 2007-08-22 2014-01-07 Koninklijke Philips N.V. System and method for displaying selected information to a person undertaking exercises
US8460189B2 (en) * 2007-09-14 2013-06-11 Corventis, Inc. Adherent cardiac monitor with advanced sensing capabilities
JP2011508615A (en) * 2007-12-07 2011-03-17 ナイキ インコーポレーティッド Cardiovascular mile
EP2874084A1 (en) * 2008-02-27 2015-05-20 NIKE Innovate C.V. Team training program
JP5643116B2 (en) * 2008-03-03 2014-12-17 ナイキ イノベイト セー. フェー. Interactive exercise equipment system
US20090292193A1 (en) * 2008-03-12 2009-11-26 Ravindra Wijesiriwardana Electrodes or sensors encapsulating embodiment for wearable physiological information monitoring straps and garments and their construction methods
CN102065751B (en) * 2008-05-01 2015-06-17 3M创新有限公司 Biomedical sensor system
US20090292194A1 (en) * 2008-05-23 2009-11-26 Corventis, Inc. Chiropractic Care Management Systems and Methods
EP2666410B1 (en) * 2008-06-02 2016-08-10 Precision Biometrics, Inc. Systems for perfoming surface electromyography and range-of-motion tests
US8192267B2 (en) * 2008-07-03 2012-06-05 Patent Investment & Licensing Company Shared game play on gaming device
US7980997B2 (en) * 2008-10-23 2011-07-19 University Of Southern California System for encouraging a user to perform substantial physical activity
US20100160117A1 (en) * 2008-12-23 2010-06-24 Club One, Inc. Apparatus and Method for Customizing Interactive Fitness Activities
US20100167876A1 (en) * 2008-12-29 2010-07-01 Tzu Chi University Radio frequency identification based exercise behavior management system
US8202202B2 (en) * 2009-01-15 2012-06-19 Mcglynn Thomas Lee Web enabled interactive aerobic training system
WO2010085688A1 (en) * 2009-01-22 2010-07-29 Under Armour, Inc. System and method for monitoring athletic performance
JP5429946B2 (en) * 2009-04-25 2014-02-26 株式会社デルタツーリング Biological condition analyzer and computer program
JP5815505B2 (en) * 2009-04-26 2015-11-17 ナイキ イノベイト セー. フェー. Exercise clock
JP5675775B2 (en) * 2009-04-27 2015-02-25 ナイキ イノベイト セー. フェー. Training program for exercise training and music playlist generation method
WO2010138975A1 (en) * 2009-05-29 2010-12-02 Sk Telecom Americas, Inc. System and method for motivating users to improve their wellness
KR20110004660A (en) * 2009-07-08 2011-01-14 한국전자통신연구원 Apparatus for measuring physiological signals
US7955219B2 (en) * 2009-10-02 2011-06-07 Precor Incorporated Exercise community system
US8500604B2 (en) * 2009-10-17 2013-08-06 Robert Bosch Gmbh Wearable system for monitoring strength training
US9451897B2 (en) * 2009-12-14 2016-09-27 Medtronic Monitoring, Inc. Body adherent patch with electronics for physiologic monitoring
KR101837481B1 (en) * 2010-03-17 2018-03-13 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 implantable biomedical devices on bioresorbable substrates
WO2011143490A2 (en) * 2010-05-12 2011-11-17 Irhythm Technologies, Inc. Device features and design elements for long-term adhesion
US20120029300A1 (en) * 2010-07-27 2012-02-02 Carefusion 303, Inc. System and method for reducing false alarms and false negatives based on motion and position sensing
WO2012040401A2 (en) * 2010-09-21 2012-03-29 Somaxis Incorporated Systems for assessing and optimizing muscular performance
US8613708B2 (en) * 2010-10-08 2013-12-24 Cardiac Science Corporation Ambulatory electrocardiographic monitor with jumpered sensing electrode
KR101747858B1 (en) * 2011-01-03 2017-06-16 삼성전자주식회사 Electrode for living body and device for measuring living body signal
JP2014514032A (en) * 2011-03-11 2014-06-19 プロテウス デジタル ヘルス, インコーポレイテッド Wearable personal body-related devices with various physical configurations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505208A (en) * 1993-12-10 1996-04-09 Toomin Research Group Method for determining muscle dysfunction
US20110118621A1 (en) * 2009-11-13 2011-05-19 Chu Tun-Hsiao Muscular energy state analysis system and method for swing motion and computer program product thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Dideriksen et al, Influence of fatigue on the simulated relation between the amplitude of the surface electromyogram and muscle force, Phil. Trans. R. Soc. A (2010) 368, 2765–2781 *
Ditor, The effect of age and gender on the relative fatigability of the human adductor pollicis muscle, Master Thesis, McMaster University, September 1999 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018110730A (en) * 2017-01-12 2018-07-19 ブリヂストンサイクル株式会社 Muscle activity state analysis system, muscle activity state analysis method and program
CN108309295A (en) * 2018-02-11 2018-07-24 宁波工程学院 A kind of arm muscular strength assessment method

Also Published As

Publication number Publication date
WO2012040390A3 (en) 2012-06-07
US10010260B2 (en) 2018-07-03
US20150313500A1 (en) 2015-11-05
US20120071770A1 (en) 2012-03-22
US20120071733A1 (en) 2012-03-22
US20120071743A1 (en) 2012-03-22
US9295424B2 (en) 2016-03-29
WO2012040401A3 (en) 2012-08-16
US11445919B2 (en) 2022-09-20
US20150305672A1 (en) 2015-10-29
WO2012040401A2 (en) 2012-03-29
US9131888B2 (en) 2015-09-15
US20120071732A1 (en) 2012-03-22
WO2012040402A2 (en) 2012-03-29
US10058265B2 (en) 2018-08-28
US20150305665A1 (en) 2015-10-29
WO2012040402A3 (en) 2012-08-02
WO2012040390A2 (en) 2012-03-29
US9107627B2 (en) 2015-08-18
US9918654B2 (en) 2018-03-20
WO2012040388A3 (en) 2012-06-14
WO2012040388A2 (en) 2012-03-29
US20160206225A1 (en) 2016-07-21

Similar Documents

Publication Publication Date Title
US9131888B2 (en) Metrics and algorithms for interpretation of muscular use
Pasadyn et al. Accuracy of commercially available heart rate monitors in athletes: a prospective study
Gillinov et al. Variable accuracy of wearable heart rate monitors during aerobic exercise
EP3153093B1 (en) Method and apparatus for generating assessments using physical activity and biometric parameters
KR102008196B1 (en) Apparatus for generating of Potassium level determination model using ECG and method thereof
FI115290B (en) Procedure and arrangement for determining the identity of a person who has made a sporting achievement
JP2017508589A (en) Health risk index determination
EP3391809A1 (en) Fitness level prediction device, system and method
Akay et al. Artificial neural network-based model for predicting VO2max from a submaximal exercise test
EP3509071A1 (en) A method and an apparatus for determining injury risk of a person based on physiological data
Brown et al. Fatigue detection in strength training using three-dimensional accelerometry and principal component analysis
Guffey et al. Estimating electromyographic and heart rate fatigue thresholds from a single treadmill test
Brandon et al. Reliability of a combined biomechanical and surface electromyographical analysis system during dynamic barbell squat exercise
Endler et al. The PerPot simulated anaerobic Threshold–A comparison to typical lactate-based thresholds
Friedl et al. With life there is motion. Activity biomarkers signal important health and performance outcomes
US10779748B2 (en) Biometric electromyography sensor device for fatigue monitoring and injury prevention and methods for using same
Mohammadzadeh et al. Prediction of physiological response over varying forecast lengths with a wearable health monitoring platform
Chiang et al. Quantification of home rehabilitation exercise for the elder's physical fitness monitoring
DeBlauw et al. Association of heart rate variability and simulated cycling time trial performance
TWI395573B (en) Calorie consumption assessment method
Caesaria et al. Effect of Muscle Fatigue on EMG Signal and Maximum Heart Rate for Pre and Post Physical Activity
Pashayeva et al. Methods and Tools for Assessing Muscle Asymmetry in the Analysis of Electromyographic Signals
URZEALĂ et al. POSSIBILITIES TO USE THE COMPUTERIZED ASSESSMENTS FOR IDENTIFYING THE EFFORT CAPACITY AND MANAGING THE FUNCTIONAL EXERTION IN MOTOR ACTIVITIES.
Ameli et al. Measurement and Validation of Exercise-Induced Fatigue Through Inertial Motion Analysis
Masood et al. Cognitive Experiments and Features for Computing Mental Stress

Legal Events

Date Code Title Description
AS Assignment

Owner name: SOMAXIS INCORPORATED, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GREY, ALEXANDER B;BELANI, ABHISHEK;HEJTMANEK, EDWARD FRANK;SIGNING DATES FROM 20110922 TO 20110927;REEL/FRAME:044276/0559

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION